sales@intentmarketresearch.com
+1 463-583-2713
According to Intent Market Research, the Gene Therapy For Rare Disease Market is expected to grow from USD 2.5 billion in 2023 at a CAGR of 8.1% to touch USD 4.3 billion by 2030. The Gene Therapy For Rare Disease Market is dominated by key players such as, Bluebird Bio, Inc., Spark Therapeutics, Regeneron Pharmaceuticals, Inc., Sangamo Therapeutics, Inc., and CRISPR Therapeutics AG.
According to Intent Market Research, the Epidermolysis Bullosa Therapeutics Market is expected to grow from USD 3.3 billion in 2023 at a CAGR of 12.2% to touch USD 7.5 billion by 2030. The Epidermolysis Bullosa Therapeutics Market is dominated by key players such as Amryt Pharma, Abeona Therapeutics Inc., Castle Creek Biosciences, Inc., Krystal Biotech, Inc., Fibrocell Science, Inc., Shire (now part of Takeda Pharmaceutical Company Limited), Regenerx Biopharmaceuticals, Wings Therapeutics, Eloxx Pharmaceuticals, ProQR Therapeutics N.V., PTC Therapeutics, Avita Medical, Mallinckrodt Pharmaceuticals, Anterogen Co., Ltd., Phoenix Tissue Repair
According to Intent Market Research, the Cochlear Implant (CI) System Market is expected to grow from USD 1.9 billion in 2023 at a CAGR of 10.8% to touch USD 4.0 billion by 2030. The Cochlear Implant (CI) System Market is dominated by key players such as, MED-EL Medical Electronics, Cochlear Limited, Nurotron Biotechnology Co., Ltd., Amplifon S.p.A., and Demant A/S.
According to Intent Market Research, the Epidermal Growth Factors Market is expected to grow from USD 2.1 billion in 2023 at a CAGR of 6.5% to touch USD 3.3 billion by 2030. The Epidermal Growth Factors Market is dominated by key players such as Amgen Inc., Merck & Co., Inc., Eli Lilly and Company, Johnson & Johnson, Pfizer Inc., Novartis AG, Sanofi S.A., Genentech, Inc., Regeneron Pharmaceuticals, Inc., GlaxoSmithKline PLC, Teva Pharmaceutical Industries Ltd., Bio-Rad Laboratories, Inc., Mylan N.V., Boehringer Ingelheim International GmbH, AbbVie Inc.
According to Intent Market Research, the Autoinjectors Market is expected to grow from USD 8.3 Billion in 2023 at a CAGR of 10.7% to touch USD 17.0 Billion by 2030. The Autoinjectors Market is dominated by key players such as AbbVie, Amgen, Antares Pharma, Bayer AG, Becton, Dickinson and Company (BD), Biogen, Johnson & Johnson, Merck & Co., Mylan (Viatris), Novartis, Regeneron Pharmaceuticals, Rochem and Teva Pharmaceutical Industries Ltd.
According to Intent Market Research, the Cardiopulmonary Autotransfusion System Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 10.0% to touch USD 3.0 billion by 2030. The Cardiopulmonary Autotransfusion System Market is dominated by key players such as, Terumo Corporation, Haemonetics Corporation, Medtronic, JUNKEN GmbH, and Baxter International Inc.
According to Intent Market Research, the Artificial Intelligence (AI) In Ultrasound Imaging Market is expected to grow from USD 3.0 Billion in 2023 at a CAGR of 24.2% to touch USD 13.5 Billion by 2030. The Artificial Intelligence (AI) In Ultrasound Imaging Market is dominated by key players such as Blackford Analysis, Butterfly Network, Canon Medical Systems, EchoNous, Esaote, Fujifilm Holdings Corporation, Hologic, Medtronic, Mindray, Philips Healthcare, Samsung Medison, Siemens Healthineers and Zebra Medical Vision.
According to Intent Market Research, the Artificial Intelligence (AI) In Oncology Market is expected to grow from USD 4.2 Billion in 2023 at a CAGR of 22.3% to touch USD 17.0 Billion by 2030. The Artificial Intelligence (AI) In Oncology Market is dominated by key players such as Aidoc, Cancer Research UK, Fujifilm Holdings, GE Healthcare, Google Health, IBM Watson Health, Microsoft, NVIDIA, PathAI, Philips Healthcare, Siemens Healthineers, Tempus and Zebra Medical Vision.
According to Intent Market Research, the Artificial Intelligence (AI) In Inflammatory Bowel Disease Market is expected to grow from USD 1.3 billion in 2023 at a CAGR of 44.5% to touch USD 17.0 billion by 2030. The Artificial Intelligence (AI) In Inflammatory Bowel Disease Market is dominated by key players such as AbbVie, AiCure, Bristol-Myers Squibb, CureMetrix, Fujifilm Holdings, GE Healthcare, Horizon Therapeutics, IBM Watson Health, IntelliHealth, Medtronic, Novartis, Siemens Healthineers and Zebra Medical Vision.
According to Intent Market Research, the Artificial Intelligence (AI) In Breast Imaging Market is expected to grow from USD 2.3 Billion in 2023 at a CAGR of 33.0% to touch USD 17.0 Billion by 2030. The Artificial Intelligence (AI) In Breast Imaging Market is dominated by key players such as Aidoc, Butterfly Network, Canon Medical Systems, Fujifilm Holdings, GE Healthcare, Hologic, Lunit, Medtronic, Mirada Medical, Philips Healthcare, ScreenPoint Medical, Siemens Healthineers, Zebra Medical Vision.
According to Intent Market Research, the Antibody Therapy Market is expected to grow from USD 83.5 Billion in 2023 at a CAGR of 11.3% to touch USD 176.3 Billion by 2030. The Antibody Therapy Market is dominated by key players such as AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celltrion Healthcare, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Regeneron Pharmaceuticals and Sanofi.
According to Intent Market Research, the Antibody Production Market is expected to grow from USD 18.1 Billion in 2023 at a CAGR of 13.5% to touch USD 44.0 Billion by 2030. The Antibody Production Market is dominated by key players such as AbbVie, Amgen, Biogen Idec, Boehringer Ingelheim, Celltrion Healthcare, Eli Lilly and Company, Mabtech, Merck & Co., Novartis, Lonza Group, Regeneron Pharmaceuticals, Roche Diagnostics and WuXi AppTec.
According to Intent Market Research, the Antibody Discovery Market is expected to grow from USD 4.9 Billion in 2023 at a CAGR of 19.4% to touch USD 17.0 Billion by 2030. The Antibody Discovery Market is dominated by key players such as Abcam, Adimab LLC, Amgen, Biogen Idec, Bristol Myers Squibb, Eli Lilly, Genmab, Lonza, MedImmune (AstraZeneca), Merck & Co., Novartis, Regeneron Pharmaceuticals and WuXi AppTec.
According to Intent Market Research, the Anti-Biofilm Wound Dressing Market is expected to grow from USD 2.3 Billion in 2023 at a CAGR of 33.0% to touch USD 17.0 Billion by 2030. The Anti-Biofilm Wound Dressing Market is dominated by key players such as 3M Health Care, Acelity (KCI), Advanced Medical Solutions Group, B. Braun Melsungen AG, Coloplast, Convatec, Hollister Incorporated, Johnson & Johnson, Medtronic, Mölnlycke Health Care, Paul Hartmann AG, Smith & Nephew and Vygon.
According to Intent Market Research, the Angioplasty Balloons Market is expected to grow from USD 3.4 Billion in 2023 at a CAGR of 10.9% to touch USD 7.1 Billion by 2030. The Angioplasty Balloons Market is dominated by key players such as Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical, Cordis Corporation (Johnson & Johnson), Medinol Ltd., Medtronic PLC, MicroPort Scientific Corporation, Raumedic AG, Smith & Nephew PLC, Surmodics, Inc. and Vascular Solutions.
According to Intent Market Research, the Anesthesia Monitoring Devices Market is expected to grow from USD 3.3 Billion in 2023 at a CAGR of 10.3% to touch USD 6.6 Billion by 2030. The Anesthesia Monitoring Devices Market is dominated by key players such as CAS Medical Systems, Inc., Drägerwerk AG & Co. KGaA, GE Healthcare, Masimo Corporation, Medtronic PLC, Mindray Medical International Limited, Nonin Medical, Inc., Osypka Medical, Philips Healthcare, Schiller AG, Siemens Healthineers and Smiths Medical.
According to Intent Market Research, the Anesthesia Drugs Market is expected to grow from USD 9.7 Billion in 2023 at a CAGR of 6.1% to touch USD 14.7 Billion by 2030. The Anesthesia Drugs Market is dominated by key players such as AbbVie Inc., Baxter International Inc., Cardinal Health, Inc., Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Medtronic PLC, Mylan N.V. (Viatris Inc.), Novartis AG, Sandoz (A Novartis Division) and Zydus Cadila.
According to Intent Market Research, the Anesthesia and Respiratory Devices Market is expected to grow from USD 19.9 Billion in 2023 at a CAGR of 7.4% to touch USD 32.9 Billion by 2030. The Anesthesia and Respiratory Devices Market is dominated by key players such as Air Liquide Medical Systems, Becton, Dickinson and Company (BD), Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., Fisher & Paykel Healthcare Corporation, GE Healthcare, Masimo Corporation, Medtronic PLC, Mindray Medical International Limited, Omron Healthcare, Philips Healthcare, ResMed Inc. and Ventec Life Systems.
According to Intent Market Research, the Anatomic Pathology Market is expected to grow from USD 42.5 Billion in 2023 at a CAGR of 7.4% to touch USD 70.0 Billion by 2030. The Anatomic Pathology Market is dominated by key players such as Abbott Laboratories, Agilent Technologies, Inc., BD Biosciences, Bio-Rad Laboratories, Canon Medical Systems Corporation, Danaher Corporation, General Electric (GE) Healthcare, Hologic, Inc., Leica Biosystems, Merck & Co., Inc., PerkinElmer, Inc., Philips Healthcare and Thermo Fisher Scientific, Inc.
According to Intent Market Research, the Anastomosis Devices Market is expected to grow from USD 3.9 Billion in 2023 at a CAGR of 6.9% to touch USD 6.2 Billion by 2030. The Anastomosis Devices Market is dominated by key players such as 3M Company, B. Braun Melsungen AG, Conmed Corporation, Cook Medical, Endo International PLC, Intuitive Surgical Inc., Karl Storz SE & Co. KG, KLS Martin Group, Medtronic PLC, Smith & Nephew PLC, Stryker Corporation, Terumo Corporation and Zimmer Biomet.
According to Intent Market Research, the Analgesics Market is expected to grow from USD USD 48.4 Billion in 2023 at a CAGR of 4.4% to touch USD 65.3 Billion by 2030. The Analgesics Market is dominated by key players such as AbbVie Inc., AstraZeneca plc, Bayer AG, Boehringer Ingelheim GmbH, Eli Lilly and Company, Endo International plc, Hikma Pharmaceuticals PLC, Johnson & Johnson, Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A. and Teva Pharmaceutical Industries Ltd.
According to Intent Market Research, the Cardiac Arrhythmia Monitoring Devices Market is expected to grow from USD 5.6 billion in 2023 at a CAGR of 10.7% to touch USD 11.3 billion by 2030. The Cardiac Arrhythmia Monitoring Devices Market is dominated by key players such as Medtronic, Abbott Laboratories, GE Healthcare, Philips Healthcare, Siemens Healthineers, Boston Scientific Corporation, Biotronik, Honeywell Life Care Solutions, Zoll Medical Corporation, Hill-Rom, Johnson & Johnson, LifeWatch (Acquired by BioTelemetry), CardioComm Solutions, Inc., Vivalink, Nuvasive, Inc.
According to Intent Market Research, the Anti-Obesity Drugs Market is expected to grow from USD 6.2 billion in 2023 at a CAGR of 28.5% to touch USD 35.9 billion by 2030. The Anti-Obesity Drugs Market is dominated by key players such as Novo Nordisk, Eli Lilly and Company, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer Inc., Orexigen Therapeutics, Sanofi S.A., AstraZeneca, Roche, AbbVie, Johnson & Johnson, Amgen Inc., Bayer AG, Mylan N.V., Allergan
According to Intent Market Research, the Industrial Microbiology Market is expected to grow from USD 4.7 billion in 2023 at a CAGR of 8.6% to touch USD 8.3 billion by 2030. The Industrial Microbiology Market is dominated by key players such as, Merck KGaA, Thermo Fisher Scientific, Lonza Group, Beckman Coulter (Danaher), and Eppendorf AG.
According to Intent Market Research, the Prenatal Vitamin Ingredients Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 10.1% to touch USD 2.3 billion by 2030. The Prenatal Vitamin Ingredients Market is dominated by key players such as, DSM Nutritional Products, BASF SE, Nature’s Way Products LLC, FBC Industries, Inc., and Kemin Industries.
According to Intent Market Research, the Amyotrophic Lateral Sclerosis Treatment Market is expected to grow from USD 4.0billion in 2023 at a CAGR of 10.7% to touch USD 8.1 billion by 2030. The Amyotrophic Lateral Sclerosis Treatment Market is dominated by key players such as AbbVie Inc., Alexion Pharmaceuticals (AstraZeneca), Amylyx Pharmaceuticals, Biogen Inc., F. Hoffmann-La Roche AG, Horizon Therapeutics, Mitsubishi Tanabe Pharma Corporation, Mylan N.V. (Viatris), Novartis AG, Regeneron Pharmaceuticals, Roche Holding AG, Sanofi S.A. and Vertex Pharmaceuticals.
According to Intent Market Research, the Surgical Energy Instruments Market is expected to grow from USD 6.9 billion in 2023 at a CAGR of 7.9% to touch USD 11.8 billion by 2030. The Surgical Energy Instruments Market is dominated by key players such as, Johnson & Johnson, Medtronic, B. Braun Melsungen AG, KLS Martin Group, and Conmed Corporation.
According to Intent Market Research, the Warm Blood Perfusion System Market is expected to grow from USD 0.4 billion in 2023 at a CAGR of 11.0% to touch USD 0.8 billion by 2030. The Warm Blood Perfusion System Market is dominated by key players such as, TransMedics, Inc., Organ Recovery Systems, Inc., Roche Diagnostics, Charles River Laboratories, and LivaNova PLC.
According to Intent Market Research, the Healthcare Information Exchange Market is expected to grow from USD 1.8 billion in 2023 at a CAGR of 8.6% to touch USD 3.2 billion by 2030. The Healthcare Information Exchange Market is dominated by key players such as, Allscripts Healthcare Solutions, Inc., Cerner Corporation, IBM Watson Health, HealthFusion, and Oracle Corporation.
According to Intent Market Research, the Biological Safety Testing Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 20.9% to touch USD 5.6 billion by 2030. The Biological Safety Testing Market is dominated by key players such as Charles River Laboratories, Lonza Group AG, Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc., SGS S.A., Eurofins Scientific, WuXi AppTec, Bio-Rad Laboratories, Inc., Toxikon Corporation, Cytovance Biologics, Avance Biosciences Inc., Paragon Bioservices (Catalent), Pacific BioLabs, Nelson Labs.
According According to Intent Market Research, the Healthcare Analytical Testing Services Market is expected to grow from USD 5.3 billion in 2023 at a CAGR of 11.1% to touch USD 11.1 billion by 2030. The Healthcare Analytical Testing Services Market is dominated by key players such as, Charles River Laboratories, Labcorp Drug Development, Medpace, Inc., BioAnalytix, and Covance (Labcorp).
According to Intent Market Research, the Genotyping Assay Market is expected to grow from USD 12.2 billion in 2023 at a CAGR of 8.3% to touch USD 21.3 billion by 2030. The Genotyping Assay Market is dominated by key players such as, Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, and PerkinElmer, Inc.
According to Intent Market Research, the Antimicrobial Hospital Textile Market is expected to grow from USD 1.1 billion in 2023 at a CAGR of 7.9% to touch USD 1.9 billion by 2030. The Antimicrobial Hospital Textile Market is dominated by key players such as, 3M Company, Medline Industries, Mölnlycke Health Care AB, Baxter International Inc., and Smith & Nephew.
According to Intent Market Research, the Advanced Balloon Catheter Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 10.7% to touch USD 5.7 billion by 2030. The Advanced Balloon Catheter Market is dominated by key players such as Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Terumo Corporation, Cook Medical, Cordis (Johnson & Johnson), Smith & Nephew PLC, Teleflex Incorporated, B. Braun Melsungen AG, AngioDynamics, Inc., Endologix, Inc., Merit Medical Systems, Inc., Philips Healthcare, Cardinal Health, Inc., MicroPort Scientific Corporation.
According to Intent Market Research, the Antiemetics Drugs Market is expected to grow from USD 4.0 billion in 2023 at a CAGR of 4.7% to touch USD 5.5 billion by 2030. The Antiemetics Drugs Market is dominated by key players such as, Merck & Co., Inc., GlaxoSmithKline Plc, Johnson & Johnson (Janssen Pharmaceuticals), Teva Pharmaceutical Industries Ltd., and Bristol-Myers Squibb.
According to Intent Market Research, the Acute Migraine Treatment Market is expected to grow from USD 1.9 billion in 2023 at a CAGR of 20.0% to touch USD 6.6 billion by 2030. The Acute Migraine Treatment Market is dominated by key players such as Amgen Inc., Eli Lilly and Co., GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Alder BioPharmaceuticals, Supernus Pharmaceuticals Inc., Cipla Ltd., Lundbeck A/S, Johnson & Johnson, Merck & Co., Inc., Sanofi S.A., AbbVie Inc., Biohaven Pharmaceuticals Holding Company.
According to Intent Market Research, the Antidote Market is expected to grow from USD 2.1 billion in 2023 at a CAGR of 6.2% to touch USD 3.1 billion by 2030. The Antidote Market is dominated by key players such as Mylan N.V. (Viatris), Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, Johnson & Johnson (Janssen Pharmaceuticals), Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Zydus Lifesciences (Cadila Healthcare), Mallinckrodt Pharmaceuticals, CSL Limited.
According to Intent Market Research, the Acute Hospital Care Market is expected to grow from USD 2,169.1 billion in 2023 at a CAGR of 6.9% to touch USD 3,456.2 billion by 2030. The Acute Hospital Care Market is dominated by key players such as HCA Healthcare, Tenet Healthcare, Mayo Clinic, Kaiser Permanente, Cleveland Clinic, Ascension Health, UPMC (University of Pittsburgh Medical Center), Universal Health Services, Catholic Health Initiatives, Community Health Systems, Fresenius Medical Care, Medtronic, GE Healthcare, Siemens Healthineers, Johnson & Johnson.
According to Intent Market Research, the Transfection Technologies Market is expected to grow from USD 1.3 billion in 2023 at a CAGR of 10.3% to touch USD 2.6 billion by 2030. The Transfection Technologies Market is dominated by key players such as, Lonza Group, Thermo Fisher Scientific, MaxCyte, Inc., Promega Corporation, and InvivoGen.
According to Intent Market Research, the Biotechnology Reagents & Kits Market is expected to grow from USD 102.7 billion in 2023 at a CAGR of 15.1% to touch USD 274.1 billion by 2030. The Biotechnology Reagents & Kits Market is dominated by key players such as Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Roche Diagnostics, Abbott Laboratories, QIAGEN N.V., Sigma-Aldrich Co. LLC, Illumina, Inc., GE Healthcare Life Sciences, Danaher Corporation, F. Hoffmann-La Roche AG, Bio-Techne Corporation, Eppendorf AG.
According to Intent Market Research, the Biotechnology Instruments Market is expected to grow from USD 80.5 billion in 2023 at a CAGR of 5.7% to touch USD 118.4 billion by 2030. The Biotechnology Instruments Market is dominated by key players such as Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Illumina Inc., PerkinElmer Inc., Merck & Co. Inc., Waters Corporation, Sartorius AG, Abbott Laboratories, Danaher Corporation, GE Healthcare Life Sciences, Beckman Coulter, Inc., Eppendorf AG, Shimadzu Corporation, Hitachi High-Technologies Corporation.
According to Intent Market Research, the Biosimilars Market is expected to grow from USD 22.2 billion in 2023 at a CAGR of 17.6% to touch USD 69.0 billion by 2030. The Biosimilars Market is dominated by key players such as Amgen Inc., Sandoz International GmbH, Pfizer Inc., Biocon Limited, Celltrion Inc., Samsung Bioepis, Mylan N.V. (Now Viatris), Eli Lilly and Co., Teva Pharmaceutical Industries Ltd., Novartis AG, AbbVie Inc., Merck & Co., Inc., Boehringer Ingelheim GmbH, Stada Arzneimittel AG, Fresenius Kabi AG.
According to Intent Market Research, the Biopsy Needle Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 11.5% to touch USD 2.0 billion by 2030. The Biopsy Needle Market is dominated by key players such as BD (Becton, Dickinson and Company), Medtronic PLC, Smith & Nephew PLC, Boston Scientific Corporation, Cook Medical, Hologic Inc., Thermo Fisher Scientific, Johnson & Johnson, F. Hoffmann-La Roche AG, Stryker Corporation, Intuitive Surgical, Olympus Corporation, B. Braun Melsungen AG, Alcon Laboratories, Biopsy Sciences.
According to Intent Market Research, the Biological Treatment Technologies Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 7.9% to touch USD 4.7 billion by 2030. The Biological Treatment Technologies Market is dominated by key players such as Veolia Environment, SUEZ.
According to Intent Market Research, the Bariatric Surgery Devices Market is expected to grow from USD 2.3 billion in 2023 at a CAGR of 8.7% to touch USD 4.2 billion by 2030. The Bariatric Surgery Devices Market is dominated by key players such as Johnson & Johnson, Kimberly-Clark Corporation, Procter & Gamble, The Clorox Company, Reckitt Benckiser Group, Unicharm Corporation, Edgewell Personal Care, Medline Industries, SC Johnson Professional, AlcoPro, Alea Care, The Honest Company, VWR International, Ecolab, Gojo Industries.
According to Intent Market Research, the Bacterial and Viral Specimen Collection Market is expected to grow from USD 18.5 billion in 2023 at a CAGR of 13.3% to touch USD 44.4 billion by 2030. The Bacterial and Viral Specimen Collection Market is dominated by key players such as Thermo Fisher Scientific, Inc., BD (Becton, Dickinson and Company), Copan Diagnostics, Inc., Hologic, Inc., Merck & Co., Inc., BioMérieux S.A., Abbott Laboratories, Charles River Laboratories, VWR International, LLC, Qiagen N.V., LabCorp, F. Hoffmann-La Roche AG, Omega Diagnostics Group PLC, PerkinElmer Inc., Tecan Group Ltd.
According to Intent Market Research, the Baby Skincare Market is expected to grow from USD 13.0 billion in 2023 at a CAGR of 8.3% to touch USD 22.7 billion by 2030. The Baby Skincare Market is dominated by key players such as Johnson & Johnson, Procter & Gamble (P&G), Unilever, Nestlé (Gerber Baby), The Himalaya Drug Company, Beiersdorf AG, L'Oréal, Aveeno (Johnson & Johnson), Burt's Bees (Clorox), Pigeon Corporation, Carter's (OshKosh), Kimberly-Clark Corporation, Chicco (Artsana Group), Mustela (Laboratoires Expanscience), Earth Mama Organics.
According to Intent Market Research, the Epilepsy Drug Market is expected to grow from USD 9.3 billion in 2023 at a CAGR of 5.2% to touch USD 13.2 billion by 2030. The Epilepsy Drug Market is dominated by key players such as Pfizer Inc., GlaxoSmithKline (GSK), Johnson & Johnson, Novartis AG, UCB Pharma, Eisai Co., Ltd., Abbott Laboratories, Sanofi, Merck & Co., Inc., Teva Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Astellas Pharma Inc., Mylan N.V., Zogenix, Inc., LivaNova.
According to Intent Market Research, the Epigenomics Market is expected to grow from USD 13.0 billion in 2023 at a CAGR of 23.5% to touch USD 56.7 billion by 2030. The Epigenomics Market is dominated by key players such as Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Merck & Co., Inc., Roche Diagnostics, Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., New England Biolabs, Inc., Promega Corporation, PerkinElmer, Inc., Bio-Techne Corporation, Zymo Research Corporation, Abcam PLC.
According to Intent Market Research, the Epigenetics Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 24.0% to touch USD 4.2 billion by 2030. The Epigenetics Market is dominated by key players such as Thermo Fisher Scientific, Inc., Illumina, Inc., Qiagen N.V., Merck KGaA, Darmstadt, Germany, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., New England Biolabs, Inc., Abcam plc, PerkinElmer, Inc., Zymo Research Corporation, Active Motif, Inc., EpigenDx, Inc., Cambridge Epigenetix Ltd., System Biosciences, Becton, Dickinson and Company.
According to Intent Market Research, the Drug Delivery Devices Market is expected to grow from USD 194.3 billion in 2023 at a CAGR of 9.2% to touch USD 359.1 billion by 2030. The Drug Delivery Devices Market is dominated by key players such as Medtronic, Johnson & Johnson, Becton, Dickinson and Company (BD), Pfizer Inc., Roche, Novo Nordisk, Stryker Corporation, Sanofi S.A., AbbVie Inc., Mylan N.V., Eli Lilly and Co., Boehringer Ingelheim, GlaxoSmithKline (GSK), Novartis AG, Merck & Co.
According to Intent Market Research, the Drug and Gene Delivery Devices Market is expected to grow from USD 370.0 billion in 2023 at a CAGR of 10.7% to touch USD 756.0 billion by 2030. The Drug and Gene Delivery Devices Market is dominated by key players such as AbbVie Inc., BD (Becton, Dickinson and Company), Medtronic, Boston Scientific Corporation, Johnson & Johnson, Stryker Corporation, Novartis AG, Pfizer Inc., Roche Holding AG, Novo Nordisk, Mylan N.V., Siemens Healthineers, Merck & Co., Inc., AstraZeneca, Sanofi S.A.
According to Intent Market Research, the DNA Microarray Market is expected to grow from USD 2.0 billion in 2023 at a CAGR of 9.2% to touch USD 3.8 billion by 2030. The DNA Microarray Market is dominated by key players such as Philips Healthcare, Medtronic PLC, GE Healthcare, Siemens Healthineers, Johnson & Johnson, Abbott Laboratories, Linde Group, Amedisys Inc., LHC Group, Inc., Fresenius Medical Care, Invacare Corporation, Baxter International Inc., ResMed Inc., Vivalto Santé, Kindred Healthcare.
According to Intent Market Research, the DNA Forensics Market is expected to grow from USD 2.3 billion in 2023 at a CAGR of 7.3% to touch USD 3.8 billion by 2030. The DNA Forensics Market is dominated by key players such as Thermo Fisher Scientific, Promega Corporation, Qiagen, Illumina, Inc., Agilent Technologies, GE Healthcare, Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Eurofins Scientific, LGC Limited, NEC Corporation, NMS Labs, Verogen, Inc., Labcorp, IntegenX.
According to Intent Market Research, the Disposable Syringes Market is expected to grow from USD 13.0 billion in 2023 at a CAGR of 7.0% to touch USD 20.8 billion by 2030. The Disposable Syringes Market is dominated by key players such as Becton, Dickinson and Company (BD), Terumo Corporation, Medtronic, Smiths Group, Fresenius Kabi AG, Nipro Corporation, Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd., Schott AG, Steris Corporation, Embulife, Abbott Laboratories, Alcon, Syringe Supplies, B. Braun Melsungen.
According to Intent Market Research, the Disposable Surgical Devices Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 12.3% to touch USD 10.4 billion by 2030. The Disposable Surgical Devices Market is dominated by key players such as Johnson & Johnson, 3M Company, Medtronic, Becton, Dickinson and Company, Cardinal Health, B. Braun Melsungen AG, Boston Scientific Corporation, Stryker Corporation, Baxter International Inc., Smith & Nephew, Mölnlycke Health Care AB, Owens & Minor, Inc., Ansell Limited, Halyard Health, Zimmer Biomet Holdings.
According to Intent Market Research, the Disease Management Apps Market is expected to grow from USD 8.3 billion in 2023 at a CAGR of 13.2% to touch USD 19.8 billion by 2030. The Disease Management Apps Market is dominated by key players such as Apple Inc., Fitbit (Owned by Google), Samsung Electronics, Medtronic, Philips Healthcare, Cerner Corporation, Allscripts Healthcare Solutions, HealthCatalyst, iHealth Labs, Livongo Health, Omron Healthcare, Dexcom, MySugr (Acquired by Roche), Healint, Pear Therapeutics.
According to Intent Market Research, the Dental Imaging Equipment Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 10.7% to touch USD 5.7 billion by 2030. The Dental Imaging Equipment Market is dominated by key players such as Sirona Dental Systems , Carestream Health, Planmeca Oy, GE Healthcare, Vatech Co., Ltd., Konica Minolta, Inc., Fujifilm Holdings Corporation, 3Shape, Ricoh Company, Ltd., Asahi Roentgen, Morita Mfg. Corp., Nobel Biocare, NewTom, Panasonic Corporation, Oraltronics.
According to Intent Market Research, the Cardiac Rhythm Management Devices Market is expected to grow from USD 17.6 billion in 2023 at a CAGR of 9.0% to touch USD 32.1 billion by 2030. The Cardiac Rhythm Management Devices Market is dominated by key players such as Medtronic, Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, St. Jude Medical (Now part of Abbott), Philips Healthcare, Stryker Corporation, MicroPort Scientific Corporation, Hoya Corporation, Medico S.p.A., Biotronik, Cook Medical, Zoll Medical Corporation, LivaNova PLC, Edwards Lifesciences Corporation.
According to Intent Market Research, the Cardiac Resynchronization Therapy Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 10.7% to touch USD 9.5 billion by 2030. The Cardiac Resynchronization Therapy Market is dominated by key players such as Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Philips Healthcare, St. Jude Medical, MicroPort Scientific Corporation, Zoll Medical Corporation, GE Healthcare, Siemens Healthineers, Biotronik, Vitatron, LivaNova PLC, SJM (St. Jude Medical), EBR Systems, Inc.
According to Intent Market Research, the Cancer Drugs Market is expected to grow from USD 203.5 billion in 2023 at a CAGR of 13.1% to touch USD 482.0 billion by 2030. The Cancer Drugs Market is dominated by key players such as Roche Holding AG, Novartis International AG, Bristol Myers Squibb, Merck & Co., Inc., AstraZeneca PLC, Pfizer Inc., Eli Lilly and Co., Johnson & Johnson, Sanofi S.A., AbbVie Inc., GlaxoSmithKline PLC, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim GmbH, Bayer AG.
According to Intent Market Research, the Uterine Fibroid Treatment Devices Market is expected to grow from USD 4.2 billion in 2023 at a CAGR of 6.6% to touch USD 6.6 billion by 2030. The Uterine Fibroid Treatment Devices Market is dominated by key players such as Medtronic, Johnson & Johnson, Boston Scientific Corporation, ConMed Corporation, Hologic, Inc., Cook Medical, AngioDynamics, Inc., EDAP TMS, Merit Medical Systems, Inc., GE Healthcare, Philips Healthcare, Siemens Healthineers, Theraclion, Biotronik, InSightec
According to Intent Market Research, the Autologous Stem Cell & Non-Stem Cell Therapies Market is expected to grow from USD 4.2 billion in 2023 at a CAGR of 26.2% to touch USD 21.3 billion by 2030. The Autologous Stem Cell & Non-Stem Cell Therapies Market is dominated by key players such as Novartis, Roche, Bristol-Myers Squibb, Gilead Sciences, Celltex Therapeutics, Mesoblast, Cytori Therapeutics, Medtronic, Biotime, Haplogen, Lonza Group, Vericel Corporation, Celyad, Kite Pharma, Bluebird Bio
According to Intent Market Research, the Autoimmune Hemolytic Anemia Treatment Market is expected to grow from USD 0.7 billion in 2023 at a CAGR of 5.9% to touch USD 1.0 billion by 2030. The Autoimmune Hemolytic Anemia Treatment Market is dominated by key players such as Pfizer Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Sanofi S.A., Novartis AG, AstraZeneca plc, Amgen Inc., Eli Lilly and Company, Johnson & Johnson Services, Inc., Biogen Inc., Takeda Pharmaceutical Company Limited, Alexion Pharmaceuticals, Inc., Merck & Co., Inc., CSL Behring, BioMarin Pharmaceutical Inc.
According to Intent Market Research, the Autoimmune Disease Diagnostics Market is expected to grow from USD 4.9 billion in 2023 at a CAGR of 6.8% to touch USD 7.7 billion by 2030. The Autoimmune Disease Diagnostics Market is dominated by key players such as Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Bio-Rad Laboratories, Danaher Corporation, Beckman Coulter, Inc., Quest Diagnostics, EUROIMMUN (A PerkinElmer Company), Inova Diagnostics, Grifols, S.A., Myriad Genetics, Trinity Biotech, Hologic, Inc., Ortho Clinical Diagnostics
According to Intent Market Research, the Artemisinin Antimalarial Drugs Market is expected to grow from USD 0.6 billion in 2023 at a CAGR of 5.8% to touch USD 0.8 billion by 2030. The Artemisinin Antimalarial Drugs Market is dominated by key players such as Novartis AG, Sanofi, Cipla Inc., IPCA Laboratories, Guilin Pharmaceutical Co. Ltd., Strides Pharma Science Limited, KPC Pharmaceuticals, Inc., Mylan N.V. (now part of Viatris), F. Hoffmann-La Roche AG, Ranbaxy Laboratories (now part of Sun Pharma), Ajanta Pharma Ltd., GlaxoSmithKline (GSK), Pfizer Inc., Bayer AG, Jiangsu Shenhua Pharmaceutical Co. Ltd.
According to Intent Market Research, the Anthrax Treatment Market is expected to grow from USD 210.7 million in 2023 at a CAGR of 8.6% to touch USD 376.6 million by 2030. The Anthrax Treatment Market is dominated by key players such as Emergent BioSolutions, GlaxoSmithKline (GSK), Pfizer Inc., Sanofi, Elusys Therapeutics, Bayer AG, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca, Johnson & Johnson, CSL Limited, Lonza Group, BioPort Corporation, Altimmune Inc.
According to Intent Market Research, the Rapid Microbiology Testing Market is expected to grow from USD 4.7 billion in 2023 at a CAGR of 9.6% to touch USD 9.0 billion by 2030. The Rapid Microbiology Testing Market is dominated by key players such as Thermo Fisher Scientific, Abbott Laboratories, BioMérieux, Danaher Corporation, Becton, Dickinson and Company (BD), Cepheid, Merck KGaA, Agilent Technologies, Luminex Corporation, Eppendorf AG, Quidel Corporation, Roche Diagnostics, IDEXX Laboratories, F. Hoffmann-La Roche, Horiba Ltd.
According to Intent Market Research, the Transitional Care Management Services Market is expected to grow from USD 196.9 billion in 2023 at a CAGR of 16.8% to touch USD 584.8 billion by 2030. The Transitional Care Management Services Market is dominated by key players such as UnitedHealth Group, Aetna Inc. (a CVS Health Company), Humana Inc., Cigna Corporation, Centene Corporation, Anthem, Inc. (now Elevance Health), Optum, Inc., Kaiser Permanente, Fresenius Medical Care, AccentCare, Inc., Encompass Health Corporation, VITAS Healthcare, Brookdale Senior Living, LHC Group, Medtronic Care Management Services
According to Intent Market Research, the Stroke Diagnostic and Therapeutics Market is expected to grow from USD 33.9 billion in 2023 at a CAGR of 7.2% to touch USD 55.3 billion by 2030. The Stroke Diagnostic and Therapeutics Market is dominated by key players such as Medtronic, Abbott Laboratories, GE Healthcare, Siemens Healthineers, Philips Healthcare, Johnson & Johnson, Stryker Corporation, Boston Scientific, Penumbra, Inc., Biogen Inc., Boehringer Ingelheim, Bayer AG, Zimmer Biomet, Toshiba Medical Systems, NeuroPace, Inc.
According to Intent Market Research, the Cognitive Behavioral Therapy Market is expected to grow from USD 5.6 billion in 2023 at a CAGR of 20.8% to touch USD 20.8 billion by 2030. The Cognitive Behavioral Therapy Market is dominated by key players such as Pear Therapeutics, Talkspace, BetterHelp, Woebot Health, MindDoc, Lumos Diagnostics, SilverCloud Health, ReGain, Cerebral, TruReach, Therapist Aid, Cogito Health, Sanvello Health, Journify, Headspace Health.
According to Intent Market Research, the Dental Flap Surgery Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 7.3% to touch USD 7.6 billion by 2030. The Dental Flap Surgery Market is dominated by key players such as Straumann Group, Nobel Biocare Services AG, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Danaher Corporation, Biomet 3i, 3M, OSSTEM Implant Co., Ltd., Henry Schein, Inc., Patterson Companies, Inc., Kavo Kerr, Implant Direct, Bicon, LLC, Dentium Co., Ltd., Carestream Dental.
According to Intent Market Research, the Voice Prosthesis Device Market is expected to grow from USD 211.9 million in 2023 at a CAGR of 4.7% to touch USD 292.1 million by 2030. The Voice Prosthesis Device Market is dominated by key players such as Atos Medical, Smith & Nephew, Medtronic, Boston Scientific, Medefil, SEKISUI Medical, Oculus Surgical, InHealth Technologies, Roche, Hollister Incorporated, B. Braun Melsungen AG, Teleflex, Vallis Surgical, Lupin Pharmaceuticals, Fisher & Paykel Healthcare
According to Intent Market Research, the GLP-1 Analogues Market is expected to grow from USD 49.5 billion in 2023 at a CAGR of 17.0% to touch USD 148.1 billion by 2030. The GLP-1 Analogues Market is dominated by key players such as Novo Nordisk, Eli Lilly and Company, Merck & Co., Inc., Sanofi, AstraZeneca, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Hanmi Pharm. Co., Ltd., D&D Pharmatech, Lexicon Pharmaceuticals, Inc., Eccogen, Xeris Pharmaceuticals, Vir Biotechnology, Amgen Inc., Boehringer Ingelheim
According to Intent Market Research, the Dental Extraction Forceps Market is expected to grow from USD 87.9 million in 2023 at a CAGR of 8.1% to touch USD 151.2 million by 2030. The Dental Extraction Forceps Market is dominated by key players such as Hu-Friedy Mfg. Co., LLC, Dentsply Sirona Inc., Aseptico Inc., Kerr Corporation, Integra LifeSciences Corporation, 3M Health Care, Henry Schein, Inc., Medtronic PLC, Friedrich August Lücke GmbH & Co. KG, GPI International, Ritter Dental, Amann Girrbach AG, Everest Dental, Spencer Instruments Inc., Brasseler USA.
According to Intent Market Research, the Clear Aligners Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 30.2% to touch USD 29.3 billion by 2030. The Clear Aligners Market is dominated by key players such as Align Technology, Inc., 3M Company, Dentsply Sirona Inc., Henry Schein, Inc., ClearCorrect, Smilify, Straumann Group, OrthoClear, Inc., Angelalign Technology Inc., Dental Morell, Candid Care Co., SmileDirectClub, Inc., G&H Orthodontics, K Line Orthodontics, Ultradent Products.
According to Intent Market Research, the Cleanroom Technology Market is expected to grow from USD 7.4 billion in 2023 at a CAGR of 7.5% to touch USD 12.3 billion by 2030. The Cleanroom Technology Market is dominated by key players such as DuPont, Kimberly-Clark Corporation, Mott Manufacturing Ltd., Clean Air Products, Terra Universal, AES Clean Technology, STEMCELL Technologies, Maclean-Fogg, Envirotech Cleanroom Solutions, Bertin Technologies, Modular Cleanrooms, Inc., Cleanroom World, U.S. Cleanrooms, Inc., Swantec Cleanroom Technology, VWR International.
According to Intent Market Research, the Cell and Gene Therapy Manufacturing Market is expected to grow from USD 6.5 billion in 2023 at a CAGR of 26.7% to touch USD 34.0 billion by 2030. The Cell and Gene Therapy Manufacturing Market is dominated by key players such as Lonza Group, WuXi AppTec, Samsung Biologics, Gilead Sciences (Kite Pharma), Novartis (AveXis), Catalent, Sartorius AG, MilliporeSigma, Bayer AG, Boehringer Ingelheim, Regeneron Pharmaceuticals, Bristol-Myers Squibb, Vertex Pharmaceuticals, Cytiva (Danaher Corporation), Oxford Biomedica
According to Intent Market Research, the Cell and Gene Therapy Clinical Trials Market is expected to grow from USD 10.2 billion in 2023 at a CAGR of 15.8% to touch USD 28.4 billion by 2030. The Cell and Gene Therapy Clinical Trials Market is dominated by key players such as Novartis, Gilead Sciences, Kite Pharma (A Gilead Company), Bristol-Myers Squibb, Bluebird Bio, Regeneron Pharmaceuticals, CRISPR Therapeutics, Sarepta Therapeutics, Editas Medicine, Spark Therapeutics (A Roche Company), Gene Editing Institute, Cell and Gene Therapy Catapult, Orchard Therapeutics, Cellectis, Allogene Therapeutics.
According to Intent Market Research, the Cardiac Monitoring Market is expected to grow from USD 19.4 billion in 2023 at a CAGR of 3.4% to touch USD 24.6 billion by 2030. The Cardiac Monitoring Market is dominated by key players such as Medtronic, Abbott Laboratories, Philips Healthcare, GE Healthcare, Boston Scientific Corporation, Siemens Healthineers, Biotronik, Johnson & Johnson, Zoll Medical Corporation, Hill-Rom, LifeWatch (Acquired by BioTelemetry), Vivalink, Nuvasive, Inc., CardioComm Solutions, Inc., BioTelemetry, Inc.
According to Intent Market Research, the Cannabis Pharmaceuticals Market is expected to grow from USD 1.9 billion in 2023 at a CAGR of 49.1% to touch USD 30.2 billion by 2030. The Cannabis Pharmaceuticals Market is dominated by key players such as GW Pharmaceuticals (Jazz Pharmaceuticals), Tilray, Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Cronos Group, Medical Marijuana, Inc., Insys Therapeutics, AbbVie Inc., MedReleaf Corp., Aphria Inc., Spectrum Therapeutics, Corbus Pharmaceuticals, Arena Pharmaceuticals, Kalytera Therapeutics, Zynerba Pharmaceuticals.
According to Intent Market Research, the Amniocentesis Needle Market is expected to grow from USD 3.0 billion in 2023 at a CAGR of 6.9% to touch USD 4.7 billion by 2030. The Amniocentesis Needle Market is dominated by key players such as Medtronic PLC, Smiths Medical, BD (Becton Dickinson and Company), Teleflex Incorporated, Cook Medical, Argon Medical Devices, Inc., Abbott Laboratories, Olympus Corporation, Hologic, Inc., Pernix Therapeutics, Stryker Corporation, Fresenius Medical Care AG and Biomet, Inc.
According to Intent Market Research, the Wavefront Aberrometers Market is expected to grow from USD 146.2 million in 2023 at a CAGR of 3.6% to touch USD 187.1 million by 2030. The Wavefront Aberrometers Market is dominated by key players such as Alcon, Bausch + Lomb, Johnson & Johnson Vision Care, Carl Zeiss Meditec AG, Nidek Co., Ltd., Topcon Corporation, Essilor International, Luneau Technology, Optos Plc, Haag-Streit AG, Ziemer Ophthalmic Systems, AMICO Group, Oculus Optikgeräte GmbH, Canon Medical Systems, Tomey Corporation.
According to Intent Market Research, the Aminophylline Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 7.4% to touch USD 2.0 billion by 2030. The Aminophylline Market is dominated by key players such as Amgen Inc., AstraZeneca PLC, Bayer AG, Cipla Limited, Dr. Reddy’s Laboratories, Fresenius Kabi AG, Merck & Co., Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Zydus Cadila.
According to Intent Market Research, the Aminoglycosides Market is expected to grow from USD 4.0 billion in 2023 at a CAGR of 7.1% to touch USD 6.4 billion by 2030. The Aminoglycosides Market is dominated by key players such as AbbVie Inc., Aurobindo Pharma, Bayer AG, Bristol-Myers Squibb Company, Fresenius Kabi AG, GSK (GlaxoSmithKline plc), Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A. and Zydus Cadila.
According to Intent Market Research, the Ambulatory Surgical Centers IT Services Market is expected to grow from USD 5.4 billion in 2023 at a CAGR of 11.7% to touch USD 11.6 billion by 2030. The Ambulatory Surgical Centers IT Services Market is dominated by key players such as, Cerner Corporation (Oracle Health), Allscripts Healthcare Solutions, NextGen Healthcare, Athenahealth, Inc., eClinicalWorks, GE Healthcare, Greenway Health, CareCloud, Inc., McKesson Corporation, Infor, Change Healthcare, Philips Healthcare and AdvancedMD, Inc.
According to Intent Market Research, the Healthcare IT Outsourcing Market is expected to grow from USD 63.9 billion in 2023 at a CAGR of 7.7% to touch USD 107.1 billion by 2030. The Healthcare IT Outsourcing Market is dominated by key players such as Accenture, IBM Corporation, Cognizant Technology Solutions, Tata Consultancy Services (TCS), Infosys Limited, Wipro Limited, DXC Technology, HCL Technologies, Atos SE, Tech Mahindra, Genpact Limited, Capgemini, Oracle Corporation, Cerner Corporation, NTT Data Corporation
According to Intent Market Research, the Healthcare ERP Market is expected to grow from USD 7.2 billion in 2023 at a CAGR of 6.7% to touch USD 11.3 billion by 2030. The Healthcare ERP Market is dominated by key players such as SAP SE, Oracle Corporation, Microsoft Corporation, Cerner Corporation, Infor, Inc., Epic Systems Corporation, McKesson Corporation, Allscripts Healthcare Solutions, Inc., Netsmart Technologies, Inc., Meditech, GE Healthcare, Ramco Systems, Sage Group, Syspro, Workday, Inc.
According to Intent Market Research, the Health Intelligent Virtual Assistant Market is expected to grow from USD 368.8 million in 2023 at a CAGR of 25.1% to touch USD 1771.1 million by 2030. The Health Intelligent Virtual Assistant Market is dominated by key players such as Nuance Communications, Google Health, Microsoft Corporation, IBM Watson Health, Amazon Web Services (AWS), Xerox Corporation, Babylon Health, Sensely, CareSkore, Infermedica, HealthTap, CureMetrix, Livi, Ada Health, Your.MD
According to Intent Market Research, the Ambulatory Surgical Center Market is expected to grow from USD 86.0 billion in 2023 at a CAGR of 6.9% to touch USD 137.0 billion by 2030. The Ambulatory Surgical Center Market is dominated by key players such as HCA Healthcare, Mednax, Surgery Partners, Tenet Healthcare, United Surgical Partners International (USPI), Ascension Health, Healthtronics, Orthopedic Centers of Colorado, Surgical Care Affiliates (SCA), Ambulatory Surgical Centers of America (ASCOA), Mercy Health, Physicians Surgery Centers, Regency Surgical Center, Surgery Center Network, American Surgical Centers.
According to Intent Market Research, the Ambulatory EHR Market is expected to grow from USD 5.6 billion in 2023 at a CAGR of 7.9% to touch USD 9.5 billion by 2030. The Ambulatory EHR Market is dominated by key players such as Epic Systems Corporation, Cerner Corporation, Allscripts Healthcare Solutions, Inc., McKesson Corporation, Athenahealth, Inc., NextGen Healthcare, MEDITECH, Greenway Health, LLC, eClinicalWorks, GE Healthcare, CureMD, Optum, Kareo, AdvancedMD, Practice Fusion.
According to Intent Market Research, the Allogeneic Cell Therapy Devices Market is expected to grow from USD 0.5 billion in 2023 at a CAGR of 22.3% to touch USD 1.9 billion by 2030. The Allogeneic Cell Therapy Devices Market is dominated by key players such as Thermo Fisher Scientific, Lonza Group, Merck KGaA, Sartorius AG, Corning Incorporated, Cytiva (Danaher Corporation), Terumo Corporation, Eppendorf AG, Bio-Techne Corporation, Miltenyi Biotec, STEMCELL Technologies, Fujifilm Irvine Scientific, CellGenix GmbH, Beckman Coulter (Danaher Corporation), Bluebird Bio, Inc.
According to Intent Market Research, the Bioreactors Market is expected to grow from USD 5.3 billion in 2023 at a CAGR of 7.3% to touch USD 8.6 billion by 2030. The Bioreactors Market is dominated by key players such as, Sartorius AG, Thermo Fisher Scientific Inc., GE Healthcare, Distek, Inc., and Applikon Biotechnology (Getinge AB).
According to Intent Market Research, the Age-Related Macular Degeneration Treatment Market is expected to grow from USD 11.1 billion in 2023 at a CAGR of 7.9% to touch USD 18.9 billion by 2030. The Age-Related Macular Degeneration Treatment Market is dominated by key players such as Regeneron Pharmaceuticals, Inc., Novartis AG, Bayer AG, Roche Holding AG, Pfizer Inc., Allergan (AbbVie), Kodiak Sciences Inc., Adverum Biotechnologies, Outlook Therapeutics, Inc., Ophthotech Corporation, Apellis Pharmaceuticals, Inc., Iveric Bio (formerly Ophthotech), Alimera Sciences, Graybug Vision, Inc., Biogen Inc.
According to Intent Market Research, the Aesthetic Devices Market is expected to grow from USD 12.0 billion in 2023 at a CAGR of 3.3% to touch USD 15.1 billion by 2030. The Aesthetic Devices Market is dominated by key players such as Allergan, Cynosure (Hologic, Inc.), Lumenis Ltd., Syneron Medical Ltd., Venus Concept, Cutera Inc., BTL Industries, Solta Medical (A division of Valeant Pharmaceuticals), Fotona, Alma Lasers, Lutronic, Hologic Inc., Merz Pharmaceuticals, Ellman International, Inc., Sciton, Inc.
According to Intent Market Research, the Acne Treatment Market is expected to grow from USD 11.1 billion in 2023 at a CAGR of 7.9% to touch USD 18.9 billion by 2030. The Acne Treatment Market is dominated by key players such as Johnson & Johnson, Galderma Laboratories, AbbVie Inc., Pfizer Inc., Almirall S.A., Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, L’Oréal S.A., Reckitt Benckiser Group plc, Nestlé Skin Health, Hologic Inc., Candela Corporation.
According to Intent Market Research, the 3D Printing in Healthcare Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 25.8% to touch USD 4.6 billion by 2030. The 3D Printing in Healthcare Market is dominated by key players such as Stratasys Ltd., 3D Systems Corporation, Materialise NV, EnvisionTEC GmbH, GE Additive, EOS GmbH, SLM Solutions Group AG, Formlabs, Inc., Carbon, Inc., Desktop Metal, Inc., Prodways Group, Renishaw plc, HP Inc., Autodesk, Inc., Organovo Holdings.
According to Intent Market Research, the 3D Printed Medical Devices Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 18.4% to touch USD 15.1 billion by 2030. The 3D Printed Medical Devices Market is dominated by key players such as GE Additive, 3D Systems Corporation, Stratasys Ltd., Materialise NV, EnvisionTEC GmbH, Renishaw plc, EOS GmbH, Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic plc, Johnson & Johnson Services, Inc., Smith & Nephew plc, Align Technology, Inc., Organovo Holdings, Inc., Proto Labs.
According to Intent Market Research, the 3D Printed Drugs Market is expected to grow from USD 92.5 million in 2023 at a CAGR of 26.2% to touch USD 472.5 million by 2030. The 3D Printed Drugs Market is dominated by key players such as GlaxoSmithKline (GSK), Merck & Co., 3D Systems Corporation, Aprecia Pharmaceuticals, BASF SE, Pfizer Inc., Stratasys Ltd., Materialise NV, Novartis AG, Trellisys Health, OrganoClick, Teva Pharmaceutical Industries Ltd., CAM Bioceramics B.V., Boehringer Ingelheim, Johnson & Johnson.
According to Intent Market Research, the Anesthesia Needles and Syringes Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 6.9% to touch USD 2.4 billion by 2030. The Anesthesia Needles and Syringes Market is dominated by key players such as B. Braun Melsungen AG, Becton, Dickinson and Company (BD), Smiths Medical, Terumo Corporation, Medtronic plc, Teleflex Incorporated, Nipro Corporation, Cardinal Health, Inc., Merit Medical Systems, Vygon SA, Boston Scientific Corporation, Ambu A/S, Cook Medical, Halyard Health (Owens & Minor), C.R. Bard (Now part of BD)
According to Intent Market Research, the Allogeneic Cell Therapy Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 19.6% to touch USD 4.2 billion by 2030. The Allogeneic Cell Therapy Market is dominated by key players such as, Cleveland Cord Blood Center, SSM Cardinal Glennon Children's Medical Center, Clinimmune Labs, University of Colorado Cord Blood Bank, Sumitomo Pharma Co., Ltd., and LifeSouth Community Blood Centers, Inc.
According to Intent Market Research, the Ambulatory Surgery Centers Market is expected to grow from USD 85.4 billion in 2023 at a CAGR of 6.7% to touch USD 134.7 billion by 2030. The Ambulatory Surgery Centers Market is dominated by key players such as Ambulatory Surgery Center Association (ASCA), AMSURG Corp., Aspen Healthcare, Eifler Consulting Services, HCA Healthcare, Medical Facilities Corporation, Proliance Surgeons, Regent Surgical Health, SurgCenter Development, Surgery Partners, Inc., Surgical Care Affiliates, TeamHealth Holdings, Inc. and United Surgical Partners International.
According to Intent Market Research, the Allergy Immunotherapy Market is expected to grow from USD 2.5 billion in 2023 at a CAGR of 10.1% to touch USD 4.9 billion by 2030. The Allergy Immunotherapy Market is dominated by key players such as, Circassia, ASIT Biotech, Merck KGaA, HAL Allergy B.V., and Allergy Therapeutics.
According to Intent Market Research, the Allergy Diagnostics and Therapeutics Market is expected to grow from USD 4.7 billion in 2023 at a CAGR of 10.1% to touch USD 9.2 billion by 2030. The Allergy Diagnostics and Therapeutics Market is dominated by key players such as, Thermo Fisher Scientific, Inc., R-Biopharm AG, AESKU.GROUP GmbH, Minaris Medical America, Inc., and Siemens Healthcare GmbH.
According to Intent Market Research, the Ambulatory Services Market is expected to grow from USD 4.3 billion in 2023 at a CAGR of 6.1% to touch USD 6.6 billion by 2030. The Ambulatory Services Market is dominated by key players such as Envision Healthcare, UnitedHealth Group, Tenet Healthcare, Surgery Partners, Fresenius Medical Care, DaVita Inc., HCA Healthcare, TeamHealth, MEDNAX, Inc., Aspen Dental Management, Inc., Terveystalo Healthcare, Sonic Healthcare, Quest Diagnostics, Laboratory Corporation of America (LabCorp), Apollo Hospitals
According to Intent Market Research, the Ambulance Services Market is expected to grow from USD 38.9 billion in 2023 at a CAGR of 9.0% to touch USD 70.9 billion by 2030. The Ambulance Services Market is dominated by key players such as Hill-Rom, Medtronic, Philips Healthcare, Smiths Medical, Allied Healthcare Products, Inc., CHAD Therapeutics, Hollister Incorporated, Thermo Fisher Scientific, Vyaire Medical, Inc., Omron Healthcare, AeroCare Holdings, MediTech, Draeger Medical, Breas Medical, Löwenstein Medical.
According to Intent Market Research, the Ambulance Equipment Market is expected to grow from USD 3.7 billion in 2023 at a CAGR of 8.7% to touch USD 6.6 billion by 2030. The Ambulance Equipment Market is dominated by key players such as Stryker Corporation, Medtronic, ZOLL Medical Corporation, Philips Healthcare, Johnson & Johnson, GE Healthcare, Becton Dickinson and Company, Smiths Medical, 3M Health Care, EMSAR, Ambulance Service Ltd., Ferno-Washington, Inc., Laerdal Medical, Bound Tree Medical, Acme Medical.
According to Intent Market Research, the Alzheimer’s Therapeutics Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 10.7% to touch USD 9.5 billion by 2030. The Alzheimer’s Therapeutics Market is dominated by key players such as Eli Lilly and Co., Biogen Inc., Roche Holding AG, Johnson & Johnson, Novartis AG, Pfizer Inc., AstraZeneca, Merck & Co., Inc., Sanofi S.A., GlaxoSmithKline PLC, Amgen Inc., Mitsubishi Tanabe Pharma, AbbVie Inc., H. Lundbeck A/S, Takeda Pharmaceutical Company.
According to Intent Market Research, the Alzheimer’s Disease Diagnostics Market is expected to grow from USD 9.3 billion in 2023 at a CAGR of 8.0% to touch USD 15.9 billion by 2030. The Alzheimer’s Disease Diagnostics Market is dominated by key players such as Roche Holding AG, Eli Lilly and Co., Biogen Inc., Siemens Healthineers AG, GE Healthcare, Johnson & Johnson, AbbVie Inc., Novartis AG, Medtronic PLC, Philips Healthcare, AstraZeneca, Quanterix Corporation, Corteva Inc., Thermo Fisher Scientific, Mindset Inc.
According to Intent Market Research, the Healthcare Transportation Services Market is expected to grow from USD 88.1 billion in 2023 at a CAGR of 7.7% to touch USD 147.7 billion by 2030. The Healthcare Transportation Services Market is dominated by key players such as American Medical Response (AMR), MedTrans (Medline Industries), Falck A/S, Veyo, LogistiCare Solutions, STG Logistics, Acadian Ambulance Service, EMS Innovations, GMR (Global Medical Response), Medstar Ambulance, AmbuCare, Air Methods Corporation, Patient Transport Services, Lifeline Ambulance Service, Care Ambulance Services
According to Intent Market Research, the Age-related Macular Degeneration Market is expected to grow from USD 8.4 billion in 2023 at a CAGR of 8.9% to touch USD 15.3 billion by 2030. The Age-related Macular Degeneration Market is dominated by key players such as AbbVie, Allergan (AbbVie), Apellis Pharmaceuticals, Bayer, Biogen, Genentech (Roche), Neovasc, Novartis, Ocular Therapeutix, Regeneron Pharmaceuticals, Roche, Senju Pharmaceutical and ThromboGenics.
According to Intent Market Research, the Aesthetic Threads Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 13.7% to touch USD 3.1 billion by 2030. The Aesthetic Threads Market is dominated by key players such as Aesthetic Works, Allergan (AbbVie Inc.), Candela Corporation, Derma Medical, Evolus, Inc., Hangzhou Aesthetic Medical Co., Ltd., Hugel Aesthetic, Hugel, Inc., Juvéderm, Lumenis Ltd., Medytox, Inc., Miracle Aesthetic and Sinclair Pharma.
According to Intent Market Research, the Aesthetic Medicine Market is expected to grow from USD 67.1 billion in 2023 at a CAGR of 10.8% to touch USD 137.8 billion by 2030. The Aesthetic Medicine Market is dominated by key players such as Allergan, Alma Lasers Ltd., BioPlus Co., Ltd., Candela Corporation, Cutera, Inc., Cynosure, LLC, Evolus, Inc., Hugel, Inc., Ipsen, Lumenis Ltd., Medytox, Inc., Revance Therapeutics, Inc. and Teoxane SA.
According to Intent Market Research, the Addiction Treatment Market is expected to grow from USD 18.6 billion in 2023 at a CAGR of 7.3% to touch USD 30.5 billion by 2030. The Addiction Treatment Market is dominated by key players such as, Alkermes plc, Indivior PLC, Cipla Limited, Dr. Reddy’s Laboratories, and Purdue Pharma L.P.
According to Intent Market Research, the Acute Repetitive Seizures Market is expected to grow from USD 1.7 billion in 2023 at a CAGR of 9.8% to touch USD 3.2 billion by 2030. The Acute Repetitive Seizures Market is dominated by key players such as, Neurelis, Inc., UCB Pharma, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, and Lundbeck A/S.
According to Intent Market Research, the Electronic Clinical Outcome Assessment (eCOA) Solutions Market is expected to grow from USD 1.8 billion in 2023 at a CAGR of 12.0% to touch USD 3.9 billion by 2030. The electronic clinical outcome assessment solutions market is dominated by key players such as Medidata Solutions, Parexel International Corporation, Veeva Systems Inc., Pharmacare, eClinicalWorks, CRF Health (now part of Signant Health), PAREXEL International, BIO-Optronics, Oracle Corporation, Qualcomm Life, WCG Clinical, Clario, CRF Health, Xcellerate, Medrio
According to Intent Market Research, the Aesthetic Surgery Procedures Market is expected to grow from USD 22.6 billion in 2023 at a CAGR of 11.1% to touch USD 47.1 billion by 2030. The Aesthetic Surgery Procedures Market is dominated by key players such as Cutera, Inc., Cynosure, LLC, Hugel, Inc., InMode Ltd., Ipsen, KLS Martin Group, Lumenis Ltd., Medytox, Inc., Merz Pharmaceuticals, Revance Therapeutics, Inc., Sciton, Inc. and Surgical Innovations Group plc.
According to Intent Market Research, the Aesthetic Injectable Market is expected to grow from USD 11.8 billion in 2023 at a CAGR of 10.7% to touch USD 24.2 billion by 2030. The Aesthetic Injectable Market is dominated by key players such as Allergan, BioPlus Co., Ltd., Bloomage Biotechnology Corporation Limited, Croma-Pharma GmbH, Daewoong Pharmaceutical Co., Ltd., Eris Lifesciences Limited, Hugel, Inc., Ipsen, Medytox, Inc., Revance Therapeutics, Inc., RevitaLash Cosmetics, Sinclair Pharma and Teoxane SA.
According to Intent Market Research, the Aesthetic Fillers Market is expected to grow from USD 5.0 billion in 2023 at a CAGR of 7.8% to touch USD 8.5 billion by 2030. The Aesthetic Fillers Market is dominated by key players such as Allergan (AbbVie), Revance Therapeutics, Ipsen, Galderma, Merz Pharmaceuticals, Medytox, Syneron Candela, Hugel, ZO Skin Health, Algeness, Fillerina, Laboratoires Vivacy, TEOXANE, Suneva Medical, Luminera
According to Intent Market Research, the Clinical Microbiology Market is expected to grow from USD 4.6 billion in 2023 at a CAGR of 6.3% to touch USD 7.1 billion by 2030. The Clinical Microbiology Market is dominated by key players such as Roche Diagnostics, Thermo Fisher Scientific, Siemens Healthineers, Abbott Laboratories, Becton, Dickinson and Company (BD), bioMérieux, QIAGEN, Hologic, Cepheid, Danaher Corporation, Beckman Coulter (A subsidiary of Danaher), Grifols, Merck KGaA, Bruker Corporation, PerkinElmer
According to Intent Market Research, the Cell and Gene Supply Chain Services Market is expected to grow from USD 1.4 billion in 2023 at a CAGR of 12.4% to touch USD 3.1 billion by 2030. The cell and gene supply chain services market is dominated by key players such as World Courier, UPS Healthcare, Kuehne + Nagel, DHL Supply Chain, FedEx, Ceva Logistics, Kerry Group, XPO Logistics, Cold Chain Technologies, Lineage Logistics, Marken, Panalpina, Air Canada Cargo, Biotec Services International, BioLife Solutions
According to Intent Market Research, the Cardiac Pacemaker Market is expected to grow from USD 5.1 billion in 2023 at a CAGR of 6.7% to touch USD 8.0 billion by 2030. The Cardiac Pacemaker Market is dominated by key players such as Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical Inc., GE Healthcare, LivaNova PLC, Medtronic PLC, MicroPort Scientific Corporation, Oscor Inc., Pacetronix, Philips Healthcare and Zoll Medical Corporation.
According to Intent Market Research, the Alpha-lipoic Acid Market is expected to grow from USD 0.7 billion in 2023 at a CAGR of 8.7% to touch USD 1.3 billion by 2030. The Alpha-lipoic Acid Market is dominated by key players such as BASF SE, Thorne Research, Inc., Mitsubishi Chemical Corporation, Roche Diagnostics, NutraScience Labs, Sigma-Aldrich Co. LLC, Jiangsu Kanion Pharmaceutical Co. Ltd., LACTONIC Pharma, Cayman Chemical Company, Kemin Industries, Natural Factors Inc., Solgar Inc., Nutraceutical International Corporation, DSM Nutritional Products, Herbalife Nutrition Ltd.
According to Intent Market Research, the Alpha-glucosidase Inhibitors Market is expected to grow from USD 3.7 billion in 2023 at a CAGR of 6.3% to touch USD 5.7 billion by 2030. The Alpha-glucosidase Inhibitors Market is dominated by key players such as Merck & Co., Inc., Boehringer Ingelheim International GmbH, Sanofi S.A., Eli Lilly and Co., Novo Nordisk, Bristol Myers Squibb, Teva Pharmaceuticals, Takeda Pharmaceutical Company Limited, Mylan N.V. (now part of Viatris Inc.), Zydus Cadila, Astellas Pharma Inc., AbbVie Inc., Pfizer Inc., Amgen Inc., Hikma Pharmaceuticals.
According to Intent Market Research, the Alpha Emitter Market is expected to grow from USD 536.5 million in 2023 at a CAGR of 13.8% to touch USD 1,323.0 million by 2030. The Alpha Emitter Market is dominated by key players such as Alpha Therapeutics, Bayer AG, AstraZeneca PLC, Eli Lilly and Co., General Electric (GE) Healthcare, Canberra Industries, Inc., Thermo Fisher Scientific, Inc., Actinium Pharmaceuticals, Curium Pharma, Lantheus Holdings, Inc., Eckert & Ziegler AG, Novartis AG, Siemens Healthineers, PharmaLogic, Ion Beam Applications.
According to Intent Market Research, the Alopecia Market is expected to grow from USD 7.4 billion in 2023 at a CAGR of 9.7% to touch USD 14.2 billion by 2030. The Alopecia Market is dominated by key players such as Regenera Activa, Johnson & Johnson, L’Oréal S.A., Procter & Gamble, GlaxoSmithKline, Bayer AG, Rogaine, Viviscal, Aclaris Therapeutics, Hairmax, Medtronic, FOLIGAIN, Revivogen, Bosley, Mercury Pharmaceuticals.
According to Intent Market Research, the Aloe Vera Extract Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 7.9% to touch USD 4.7 billion by 2030. The Aloe Vera Extract Market is dominated by key players such as Aloe Laboratories, Inc., Forever Living Products, Terry Laboratories, Lily of the Desert Organic Aloeceuticals, Foodchem International Corporation, Aloecorp, Inc., Herbalife Nutrition, Aloecorp (IASC), Pharmachem Laboratories, Inc., Aloe Vera Australia, Aloe Farms, Inc., Sarvliving, Natural Aloe Costa Rica, Patanjali Ayurved Limited, Fruit of the Earth, Inc.
According to Intent Market Research, the Alginate Dressing Market is expected to grow from USD 2.3 billion in 2023 at a CAGR of 10.1% to touch USD 4.5 billion by 2030. The Alginate Dressing Market is dominated by key players such as 3M Health Care, Acelity (Now part of 3M), B. Braun Melsungen AG, Cardinal Health, Coloplast A/S, ConvaTec Group, Hollister Incorporated, KCI Medical, Medline Industries, Inc., Medtronic PLC, Mölnlycke Health Care and Systagenix Wound Management.
According to Intent Market Research, the Diabetes Care Devices Market is expected to grow from USD 41.6 billion in 2023 at a CAGR of 11.2% to touch USD 87.4 billion by 2030. The Diabetes Care Devices Market is dominated by key players such as Medtronic, Abbott Laboratories, Roche Diagnostics, Dexcom, Becton, Dickinson and Company, Insulet Corporation, Johnson & Johnson, Novo Nordisk, Sanofi, Terumo Corporation, F. Hoffmann-La Roche Ltd, Tandem Diabetes Care, Bayer AG, Eli Lilly and Company, GlaxoSmithKline (GSK).
According to Intent Market Research, the Alexipharmic Drugs Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 6.9% to touch USD 2.4 billion by 2030. The Alexipharmic Drugs Market is dominated by key players such as AbbVie Inc., AstraZeneca, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., Eisai Co., Ltd., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer Inc. and Takeda Pharmaceutical Company Limited.
According to Intent Market Research, the Contact Lenses Market is expected to grow from USD 16.7 billion in 2023 at a CAGR of 8.9% to touch USD 30.2 billion by 2030. The Contact Lenses Market is dominated by key players such as Johnson & Johnson Vision Care, Inc., Alcon Inc., Bausch + Lomb, CooperVision, Inc., EssilorLuxottica Group, Carl Zeiss Vision, Hoya Corporation, Menicon Co., Ltd., Ciba Vision, The Sight Company, Contamac Ltd., Acuvue (Johnson & Johnson Vision Care), Vision Care Optical, UltraVision CLPL, X-Cel Specialty Contacts.
According to Intent Market Research, the Alcohol Wipes Market is expected to grow from USD 604.5 million in 2023 at a CAGR of 6.4% to touch USD 930.8 million by 2030. The Alcohol Wipes Market is dominated by key players such as Johnson & Johnson, Kimberly-Clark Corporation, Procter & Gamble, The Clorox Company, Reckitt Benckiser Group, Unicharm Corporation, Edgewell Personal Care, Medline Industries, SC Johnson Professional, AlcoPro, Alea Care, The Honest Company, VWR International, Ecolab, Gojo Industries.
According to Intent Market Research, the Albumin Market is expected to grow from USD 5.6 billion in 2023 at a CAGR of 7.9% to touch USD 9.5 billion by 2030. The Albumin Market is dominated by key players such as Grifols, CSL Behring, Shire (Takeda Pharmaceutical Company), Octapharma, Biotest AG, Sichuan Yuanda Shuyang Pharmaceutical, Eli Lilly and Company, Fresenius Kabi, Baxter International Inc., Sanofi, AbbVie, Emergent BioSolutions, Shanghai RAAS Blood Products Co. Ltd., Jiangsu Kanion Pharmaceutical Co. Ltd., Hualan Biological Engineering.
According to Intent Market Research, the Airway Clearance Systems Market is expected to grow from USD 0.6 billion in 2023 at a CAGR of 10.7% to touch USD 1.1 billion by 2030. The Airway Clearance Systems Market is dominated by key players such as Hill-Rom, Medtronic, Philips Healthcare, Smiths Medical, Allied Healthcare Products, Inc., CHAD Therapeutics, Hollister Incorporated, Thermo Fisher Scientific, Vyaire Medical, Inc., Omron Healthcare, AeroCare Holdings, MediTech, Draeger Medical, Breas Medical, Löwenstein Medical.
According to Intent Market Research, the Advanced Drug Delivery Market is expected to grow from USD 239.4 billion in 2023 at a CAGR of 5.8% to touch USD 354.9 billion by 2030. The Advanced Drug Delivery Market is dominated by key players such as Johnson & Johnson, Pfizer Inc., Roche Holding AG, Novartis AG, Merck & Co., Inc., Sanofi S.A., GlaxoSmithKline plc, AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Medtronic PLC, Mylan N.V.
According to Intent Market Research, the 5G in Healthcare Market is expected to grow from USD 47.0 billion in 2023 at a CAGR of 32.6% to touch USD 338.1 billion by 2030. The 5G in Healthcare Market is dominated by key players such as Verizon Communications, AT&T Inc., Huawei Technologies Co., Ltd., Ericsson AB, Qualcomm Technologies, Inc., Samsung Electronics Co., Ltd., Vodafone Group Plc, Siemens Healthineers AG, GE Healthcare, Philips Healthcare, Intel Corporation, T-Mobile US, BT Group, ZTE Corporation, Ciena Corporation
According to Intent Market Research, the AI in Pharmaceutical Market is expected to grow from USD 2.7 billion in 2023 at a CAGR of 13.9% to touch USD 6.8 billion by 2030. The AI in Pharmaceutical Market is dominated by key players such as, Google LLC (Alphabet Inc.), IBM Corporation, NVIDIA Corporation, BenevolentAI, and Atomwise, Inc.
According to Intent Market Research, the AI in Medical Writing Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 24.4% to touch USD 5.7 billion by 2030. The AI in Medical Writing Market is dominated by key players such as Accenture, Cerner Corporation, Cognizant Technology Solutions, Elsevier, IBM Watson Health, IQVIA, Medtronic, Nuance Communications, Parexel International, Veeva Systems, Veristat and Wiley.
According to Intent Market Research, the AI in Genomics Market is expected to grow from USD 3.2 billion in 2023 at a CAGR of 22.0% to touch USD 13.0 billion by 2030. The AI in Genomics Market is dominated by key players such as Agilent Technologies, BenevolentAI, Bristol-Myers Squibb, Deep Genomics, IBM Watson Health, Illumina, Insilico Medicine, Qiagen, Tempus, Thermo Fisher Scientific, and XtalPi.
According to Intent Market Research, the AI in Epidemiology Market is expected to grow from USD 431.7 million in 2023 at a CAGR of 15.2% to touch USD 1,162.1 million by 2030. The AI in Epidemiology Market is dominated by key players such as, Google LLC (Alphabet Inc.), IBM Corporation, Accenture plc, Tempus Labs, and BlueDot.
According to Intent Market Research, the AI in Biotechnology Market is expected to grow from USD 5.2 billion in 2023 at a CAGR of 22.2% to touch USD 21.1 billion by 2030. The AI in Biotechnology Market is dominated by key players such as Atomwise, BASF SE, Bayer AG, Exscientia, Google Health (Alphabet Inc.), IBM Watson Health, Intel Corporation, Microsoft Corporation, NVIDIA Corporation, Schrödinger Inc., and SRI International.
According to Intent Market Research, the AI in Biopharmaceutical Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 17.2% to touch USD 3.7 billion by 2030. The AI in Biopharmaceutical Market is dominated by key players such as, Google LLC (Alphabet Inc.), IBM Corporation, Accenture plc, Tempus Labs, and Insilico Medicine.
According to Intent Market Research, the AI in Revenue Cycle Management Market is expected to grow from USD 6.3 billion in 2023 at a CAGR of 14.8% to touch USD 16.5 billion by 2030. The AI in Revenue Cycle Management Market is dominated by key players such as 3M Health Information Systems, Allscripts Healthcare Solutions, Cerner Corporation, Change Healthcare, Cognizant Technology Solutions, Epic Systems Corporation, GeBBS Healthcare Solutions, McKesson Corporation, NaviNet (a part of NantHealth), Nextech Systems, NextGen Healthcare and Optum (UnitedHealth Group).
According to Intent Market Research, the AI in Precision Medicine Market is expected to grow from USD 5.6 billion in 2023 at a CAGR of 16.6% to touch USD 16.5 billion by 2030. The AI in Precision Medicine Market is dominated by key players such as Butterfly Network, Inc., Cerner Corporation, GE Healthcare, Health Catalyst, IBM Corporation, Illumina, Inc., Medtronic, Microsoft Corporation, NVIDIA Corporation, PathAI, Philips Healthcare, and Siemens Healthineers.
According to Intent Market Research, the Healthcare Finance Solutions Market is expected to grow from USD 134.6 billion in 2023 at a CAGR of 5.3% to touch USD 193.2 billion by 2030. The Healthcare Finance Solutions Market is dominated by key players such as, McKesson Corporation, Cerner Corporation, Athenahealth, Inc., Siemens Healthineers, and Meditech.
According to Intent Market Research, the Healthcare Cybersecurity Market is expected to grow from USD 17.5 billion in 2023 at a CAGR of 13.2% to touch USD 41.6 billion by 2030. The Healthcare Cybersecurity Market is dominated by key players such as, Fortinet, Inc., Cisco Systems, Inc., Check Point Software Technologies Ltd., CyberArk Software Ltd., and Trend Micro Incorporated.
According to Intent Market Research, the Healthcare Asset Management Market is expected to grow from USD 8.8 billion in 2023 at a CAGR of 12.7% to touch USD 20.3 billion by 2030. The Healthcare Asset Management Market is dominated by key players such as Ascom Holding AG, AssetWorks LLC, AT&T Inc., Cognizant Technology Solutions, GE Healthcare, Honeywell International Inc., Medtronic, Oracle Corporation, Philips Healthcare, Siemens Healthineers, Stanley Healthcare, Stryker Corporation and Zebra Technologies Corporation.
According to Intent Market Research, the Vendor Neutral Archive (VNA) & PACS Market is expected to grow from USD 4.3 billion in 2023 at a CAGR of 8.2% to touch USD 7.4 billion by 2030. The Vendor Neutral Archive (VNA) & PACS Market is dominated by key players such as Agfa HealthCare, Carestream Health, Change Healthcare, Dell Technologies, Fujifilm Holdings Corporation, GE Healthcare, Hyland Software, IBM Watson Health, Intelerad Medical Systems, Mach7 Technologies, Merge Healthcare (an IBM Company), Novarad Corporation, Philips Healthcare, Sectra AB, Siemens Healthineers.
According to Intent Market Research, the Surgical Robot Accessories Market is expected to grow from USD 3.7 billion in 2023 at a CAGR of 22.7% to touch USD 15.6 billion by 2030. The Surgical Robot Accessories Market is dominated by key players such as, Stryker Corporation, Intuitive Surgical, Inc., Johnson & Johnson, Mazor Robotics, and Smith & Nephew.
According to Intent Market Research, the Vascular Ulcers Treatment Market is expected to grow from USD 4.1 billion in 2023 at a CAGR of 8.9% to touch USD 7.4 billion by 2030. The Vascular Ulcers Treatment Market is dominated by key players such as 3M Health Care, Acelity, Acelity, B. Braun Melsungen AG, Cardinal Health, Coloplast, Convatec Group, DermaRite Industries, LLC, Hollister Incorporated, Johnson & Johnson, Medline Industries, Inc., Medtronic, Molnlycke Health Care, Mölnlycke Health Care, Smith & Nephew.
According to Intent Market Research, the Micropump Market is expected to grow from USD 2.2 billion in 2023 at a CAGR of 13.8% to touch USD 5.5 billion by 2030. The Micropump Market is dominated by key players such as Bartels Mikrotechnik GmbH, Bürkert Fluid Control Systems, Dolomite Microfluidics, IDEX Corporation, KNF Group, Micropump, Takako Industries, Inc., The Lee Company, TTP Ventus Ltd, Xiamen AJK Technology Co., Ltd.
According to Intent Market Research, the Vaccine Contract Manufacturing Market is expected to grow from USD 1.9 billion in 2023 at a CAGR of 8.8% to touch USD 3.5 billion by 2030. The Vaccine Contract Manufacturing Market is dominated by key players such as Bausch Health, Boehringer Ingelheim, Catalent, Inc., CordenPharma, Emergent BioSolutions, GlaxoSmithKline, Lonza Group AG, Recipharm AB, Samsung Biologics, Sanofi Pasteur, Serum Institute of India, Takeda Pharmaceutical Company, Vaccines Manufacturing, Inc. (VMI), Vetter Pharma International, WuXi AppTec.
According to Intent Market Research, the Medical Device Cybersecurity Solutions Market is expected to grow from USD 7.2 billion in 2023 at a CAGR of 15.2% to touch USD 19.3 billion by 2030. The Medical Device Cybersecurity Solutions Market is dominated by key players such as, Johnson & Johnson, Medtronic PLC, GE Healthcare, Check Point Software Technologies, and CrowdStrike.
According to Intent Market Research, the Advanced Wound Dressing Market is expected to grow from USD 10.3 billion in 2023 at a CAGR of 9.6% to touch USD 19.6 billion by 2030. The Advanced Wound Dressing Market is dominated by key players such as Smith & Nephew PLC, Johnson & Johnson, 3M Health Care, Molnlycke Health Care, Coloplast A/S, ConvaTec Group PLC, BSN Medical, Hollister Incorporated, MediWound Ltd., KCI (Acelity), Derma Sciences (Integra LifeSciences), Systagenix Wound Management, Hartmann Group, Fresenius Kabi, Advanced Medical Solutions Group.
According to Intent Market Research, the Advanced Therapy Medicinal Products CDMO Market is expected to grow from USD 5.2 billion in 2023 at a CAGR of 21.6% to touch USD 20.4 billion by 2030. The Advanced Therapy Medicinal Products CDMO Market is dominated by key players such as Lonza Group, Samsung Biologics, WuXi AppTec, Boehringer Ingelheim, Catalent, Kite Pharma (Gilead Sciences), Novartis (Kymriah), Sartorius Stedim Biotech, Regeneron Pharmaceuticals, VWR International, Cell and Gene Therapy Catapult, WuXi Advanced Therapies, AbbVie, Baxter International, Merck Group.
According to Intent Market Research, the Advanced Ophthalmology Technology Market is expected to grow from USD 7.7 billion in 2023 at a CAGR of 7.1% to touch USD 12.4 billion by 2030. The Advanced Ophthalmology Technology Market is dominated by key players such as Alcon, Johnson & Johnson Vision, Carl Zeiss Meditec AG, Bausch + Lomb, AbbVie (Allergan), Santen Pharmaceutical Co., Ltd., Hoya Corporation, Novartis AG, TearLab Corporation, Topcon Corporation, Rayner Intraocular Lenses Ltd., Nidek Co., Ltd., Medtronic, Olympus Corporation, Lumenis Ltd.
According to Intent Market Research, the Advanced Bipolar Direct Energy Devices Market is expected to grow from USD 3.0 billion in 2023 at a CAGR of 11.5% to touch USD 6.3 billion by 2030. The Advanced Bipolar Direct Energy Devices Market is dominated by key players such as Analog Devices, Inc., Broadcom Inc., Cree, Inc., Infineon Technologies, Maxim Integrated, Microchip Technology Inc., NXP Semiconductors N.V., ON Semiconductor, Qualcomm Technologies, Inc., Renesas Electronics Corporation, Semtech Corporation, STMicroelectronics, Texas Instruments Inc., Toshiba Corporation, Vishay Intertechnology, Inc.
According to Intent Market Research, the Advance Care Planning Solutions Market is expected to grow from USD 93.9 billion in 2023 at a CAGR of 13.8% to touch USD 232.2 billion by 2030. The Advance Care Planning Solutions Market is dominated by key players such as Advance Care Planning Australia, Amedisys, CareSimple, Delmarva Foundation for Medical Care, ePOLST, HealthCare Interactive, Honoring Choices, LifeBio, MyDirectives, Palliative Care Center, Pathways Health.
According to Intent Market Research, the Adult Vitamin Gummies Market is expected to grow from USD 4.3 billion in 2023 at a CAGR of 7.2% to touch USD 7.1 billion by 2030. The Adult Vitamin Gummies Market is dominated by key players such as Amway, Bayer, Church & Dwight Co., DSM, General Nutrition Centers Inc. (GNC), Hero Nutritionals, Jamieson, Nature’s Bounty Inc., Nature’s Way, Pfizer Inc., Pharmavite, Puritan's Pride, Sanofi, Smarty Pants Vitamins, Webber Naturals.
According to Intent Market Research, the Cytotoxic Drugs Market is expected to grow from USD 14.1 billion in 2023 at a CAGR of 10.4% to touch USD 28.2 billion by 2030. The Cytotoxic Drugs Market is dominated by key players such as AbbVie Inc., Amgen Inc., AstraZeneca plc, Baxter International Inc., Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson and Merck & Co., Inc.
According to Intent Market Research, the Breast Shells Market is expected to grow from USD 341.6 million in 2023 at a CAGR of 10.5% to touch USD 685.7 million by 2030. The Breast Shells Market is dominated by key players such as, Ardo Medical Ltd., Ameda Inc., Medela AG, Lacticups, and Newell Brands.
According to Intent Market Research, the Breast Cancer Liquid Biopsy Market is expected to grow from USD 1.1 billion in 2023 at a CAGR of 14.7% to touch USD 2.9 billion by 2030. The Breast Cancer Liquid Biopsy Market is dominated by key players such as, NeoGenomics Laboratories, The Menarini Group, Thermo Fisher Scientific, Inc., Epic Sciences, Inc., and Biocept, Inc.
According to Intent Market Research, the Bovine Tuberculosis Diagnosis Market is expected to grow from USD 585.4 million in 2023 at a CAGR of 5.8% to touch USD 871.3 million by 2030. The Bovine Tuberculosis Diagnosis Market is dominated by key players such as, PBD Biotech Ltd, IDEXX Laboratories, Inc., Thermo Fisher Scientific Inc., Bionote USA Inc., and AsureQuality Australia Pty Ltd.
According to Intent Market Research, the Bone Morphogenetic Protein Market is expected to grow from USD 472.2 million in 2023 at a CAGR of 6.6% to touch USD 738.7 million by 2030. The Bone Morphogenetic Protein Market is dominated by key players such as, Cellumed Co., Ltd., Medtronic plc, Prospec-Tany Technogene Ltd., Proteintech Group, Inc., and Bio-Techne.
According to Intent Market Research, the Bone Grafts and Substitutes Market is expected to grow from USD 5.7 billion in 2023 at a CAGR of 11.7% to touch USD 12.3 billion by 2030. The Bone Grafts And Substitutes Market is dominated by key players such as, DePuy Synthes (Johnson & Johnson), AlloSource, Smith + Nephew, Zimmer Biomet, and Orthofix Medical, Inc..
According to Intent Market Research, the Artificial Disc Replacement Market is expected to grow from USD 1.0 billion in 2023 at a CAGR of 11.5% to touch USD 2.2 billion by 2030. The Artificial Disc Replacement Market is dominated by key players such as Aesculap Implant Systems, LLC, AxioMed LLC, B. Braun Melsungen AG, Centinel Spine, LLC, DePuy Synthes (Johnson & Johnson), Globus Medical, Inc., LDR Holding Corporation, Medtronic PLC and NuVasive, Inc.
According to Intent Market Research, the Aquatic Ecotoxicological Studies Market is expected to grow from USD 444.6 million in 2023 at a CAGR of 7.8% to touch USD 751.5 million by 2030. The Aquatic Ecotoxicological Studies Market is dominated by key players such as ALS Limited, Bioresearch Center (BRC), Burleson Research Technologies, Charles River Laboratories, EAG Laboratories, Envigo and Eurofins Scientific.
According to Intent Market Research, the AI-Based Surgical Robots Market is expected to grow from USD 7.5 billion in 2023 at a CAGR of 22.8% to touch USD 31.3 billion by 2030. The AI-Based Surgical Robots Market is dominated by key players such as, Stryker Corporation, Intuitive Surgical Inc., Zimmer Biomet Holdings Inc., Vicarious Surgical Inc., and Asensus Surgical Inc.
According to Intent Market Research, the Bone Allografts Market is expected to grow from USD 2.7 billion in 2023 at a CAGR of 10.3% to touch USD 5.3 billion by 2030. The Bone Allografts Market is dominated by key players such as, Medtronic, Zimmer Biomet, Lynch Biologics, LLC., Baxter, and Johnson & Johnson Services, Inc.
According to Intent Market Research, the AI In Patient Engagement Solutions Market is expected to grow from USD 5.7 billion in 2023 at a CAGR of 21.7% to touch USD 22.6 billion by 2030. The AI In Patient Engagement Solutions Market is dominated by key players such as, Cerner Corporation, Philips Healthcare, IBM Watson Health, Allscripts Healthcare Solutions, and Qualcomm Life.q
According to Intent Market Research, the AI in Medical Imaging Market is expected to grow from USD 2.7 billion in 2023 at a CAGR of 17.8% to touch USD 8.5 billion by 2030. The AI in Medical Imaging Market is dominated by key players such as, GE Healthcare, Siemens Healthineers, Canon Medical Systems Corporation, Zebra Medical Vision, and NVIDIA Corporation.
According to Intent Market Research, the AI in Medical Coding Market is expected to grow from USD 2.5 billion in 2023 at a CAGR of 14.1% to touch USD 6.4 billion by 2030. The AI in Medical Coding Market is dominated by key players such as, Optum Inc., 3M Health Information Systems, Ciox Health, Cerner Corporation, and nThrive Inc.
Blood Processing Devices & Consumables Market By Product (Devices, Consumables), By End-use (Hospitals and Clinics, Diagnostic Laboratories), and By Region; Global Insights & Forecast (2024 – 2030)
According to Intent Market Research, the Adipose Derived Stem Cell Therapy Market is expected to grow from USD 12.3 billion in 2023 at a CAGR of 11.7% to touch USD 26.6 billion by 2030. The Adipose Derived Stem Cell Therapy Market is dominated by key players such as Anterogen Co., Ltd., Athersys, Inc., Celltex Therapeutics Corporation, ExCellThera, Inc., Haplogen GmbH, IsuAbxis and Mesoblast Ltd.
According to Intent Market Research, the Behavioral Rehabilitation Market is expected to grow from USD 228.4 billion in 2023 at a CAGR of 3.4% to touch USD 289.0 billion by 2030. The Behavioral Rehabilitation Market is dominated by key players such as AbbVie Inc., Amedisys, Inc., Boston Scientific Corporation, Cerner Corporation, Cigna Corporation, Cognizant Technology Solutions, HCA Healthcare, Inc. and Huntington Ingalls Industries.
According to Intent Market Research, the Baby Oral Care Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 4.3% to touch USD 2.0 billion by 2030. The Baby Oral Care Market is dominated by key players such as Babyganics (Evergreen Innovation Group), Church & Dwight Co., Inc., Colgate-Palmolive Company, GlaxoSmithKline, Hain Celestial Group, Inc., Himalaya Drug Company, Johnson & Johnson, Kimberly-Clark Corporation and Lion Corporation.
According to Intent Market Research, the Amniotic Membrane Market is expected to grow from USD 3.6 billion in 2023 at a CAGR of 14.1% to touch USD 9.1 billion by 2030. The Amniotic Membrane Market is dominated by key players such as Amniox Medical, Inc., Applied Biologics, Athersys, Inc., Celgene Corporation, Human Regenerative Therapy, Inc., Integra LifeSciences and Kerecis.
According to Intent Market Research, the Amines Market is expected to grow from USD 21.1 billion in 2023 at a CAGR of 5.8% to touch USD 31.3 billion by 2030. The Amines Market is dominated by key players such as BASF SE, Air Products and Chemicals, Inc., AkzoNobel N.V., China National Petroleum Corporation (CNPC), Dow Chemical Company, Eastman Chemical Company, Huntsman Corporation, Indo Amines Limited and Kraton Polymers.
According to Intent Market Research, the Autotransfusion Devices Market is expected to grow from USD 504.7 million in 2023 at a CAGR of 7.6% to touch USD 841.7 million by 2030. The Autotransfusion Devices Market is dominated by key players such as Baxter International Inc., Biomet, Fresenius Medical Care, Grifols S.A., Haemonetics Corporation, LivaNova PLC, Macopharma and Medtronic.
According to Intent Market Research, the Genetic Analysis Services Market is expected to grow from USD 3.1 billion in 2023 at a CAGR of 19.3% to touch USD 10.5 billion by 2030. The Genetic Analysis Services Market is dominated by key players such as 23andMe, Inc., Agilent Technologies, Inc., BGI Group, Bio-Rad Laboratories, Inc., Cepheid, Eurofins Scientific, Illumina, Inc., LabCorp (Covance), MedGenome Labs, Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., PerkinElmer, Inc., QIAGEN N.V., Roche Holding AG, Thermo Fisher Scientific.
According to Intent Market Research, the Amyloidosis Treatment Market is expected to grow from USD 3.3 billion in 2023 at a CAGR of 8.1% to touch USD 5.6 billion by 2030. The Amyloidosis Treatment Market is dominated by key players such as, Johnson & Johnson Services, Inc., Pfizer Inc., Amgen Inc., F. Hoffmann-La Roche Ltd, and Novartis AG.
According to Intent Market Research, the Diabetic Foot Ulcer Treatment Market is expected to grow from USD 4.4 billion in 2023 at a CAGR of 7.3% to touch USD 7.1 billion by 2030. The Diabetic Foot Ulcer Treatment Market is dominated by key players such as, B. Braun Melsungen, 3M, ConvaTec, Smith & Nephew, and Integra LifeSciences.
According to Intent Market Research, the Oligonucleotide Synthesis Market is expected to grow from USD 8.1 billion in 2023 at a CAGR of 12.9% to touch USD 19.0 billion by 2030. The Oligonucleotide Synthesis Market is dominated by key players such as Agilent Technologies, Inc., Beckman Coulter, Inc., Bioneer Corporation, Biosearch Technologies, Inc., DNA Script, Eurofins Genomics, GE Healthcare Life Sciences, Illumina, Inc. and Integrated DNA Technologies, Inc.
According to Intent Market Research, the DNA Sequencing Market is expected to grow from USD 13.7 billion in 2023 at a CAGR of 26.3% to touch USD 70.0 billion by 2030. The DNA Sequencing Market is dominated by key players such as Abbott Laboratories, ACGT Corporation, Agilent Technologies, Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Danaher Corporation, Genomic Health, Inc., Illumina, Inc. and Oxford Nanopore Technologies Ltd.
According to Intent Market Research, the Acromegaly Treatment Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 10.2% to touch USD 2.9 billion by 2030. The Acromegaly Treatment Market is dominated by key players such as Alexion Pharmaceuticals (AstraZeneca), Amgen Inc., Chugai Pharmaceutical Co., Ltd., Eli Lilly and Company, Merck & Co., Inc., Novartis International AG, and Pfizer Inc.
According to Intent Market Research, the Antiarrhythmic Drugs Market is expected to grow from USD 1.7 billion in 2023 at a CAGR of 8.3% to touch USD 2.9 billion by 2030. The Antiarrhythmic Drugs Market is dominated by key players such as, Novartis, Pfizer, Sanofi, Upsher-Smith Laboratories, and Mayne Pharma.
According to Intent Market Research, the Ambient Assisted Living Market is expected to grow from USD 9.6 billion in 2023 at a CAGR of 11.6% to touch USD 20.7 billion by 2030. The Ambient Assisted Living Market is dominated by key players such as, Assisted Living Technologies, Inc., 2PCS Solutions GmbH, Bay Alarm Medical, Legrand Group España, S.L., and ADT.
According to Intent Market Research, the AI In Patient Engagement Market is expected to grow from USD 5.9 billion in 2023 at a CAGR of 20.5% to touch USD 21.8 billion by 2030. The AI In Patient Engagement Market is dominated by key players such as Allscripts Healthcare Solutions, Amazon Web Services (AWS), Cerner Corporation, Cognizant Healthcare Solutions, Epic Systems Corporation, GE Healthcare, Google Health and IBM Watson Health.
According to Intent Market Research, the AI In Mental Health Market is expected to grow from USD 1.1 billion in 2023 at a CAGR of 36.9% to touch USD 10.0 billion by 2030. The AI In Mental Health Market is dominated by key players such as Ada Health, Bark Technologies, BetterHelp. Big Health, Ginger, Happify Health, Lyra Health and Meru Health.
According to Intent Market Research, the Airway Management Devices Market is expected to grow from USD 3.1 billion in 2023 at a CAGR of 8.1% to touch USD 5.4 billion by 2030. The Airway Management Devices Market is dominated by key players such as, Teleflex Incorporated, Medtronic, BD, ICU Medical (Smiths Medical, Inc.), and Armstrong Medical Ltd.
According to Intent Market Research, the Advanced Wound Care Market is expected to grow from USD 10.3 billion in 2023 at a CAGR of 6.2% to touch USD 15.6 billion by 2030. The Advanced Wound Care Market is dominated by key players such as Mölnlycke Health Care AB, 3M, Smith & Nephew, Baxter International, Cardinal Health, Medline Industries, Inc., ConvaTec Inc. and Johnson & Johnson Services, Inc.
According to Intent Market Research, the Adult Stem Cells Market is expected to grow from USD 11.4 billion in 2023 at a CAGR of 13.7% to touch USD 27.9 billion by 2030. The Adult Stem Cells Market is dominated by key players such as Thermo Fisher Scientific, Inc., STEMCELL Technologies, Osiris Therapeutics, Vericel Corporation, ZenBio, Inc., and Stempeutics Research.
According to Intent Market Research, the Cancer Biomarkers Market is expected to grow from USD 19.7 billion in 2023 at a CAGR of 6.8% to touch USD 31.2 billion by 2030. The Cancer Biomarkers Market is dominated by key players such as, Agilent Technologies, Inc., Abbott Laboratories, Genomic Health, Inc., QIAGEN N.V., and Hologic, Inc.
According to Intent Market Research, the Acute Ischemic Stroke Therapeutics Market is expected to grow from USD 8.6 billion in 2023 at a CAGR of 5.9% to touch USD 12.8 billion by 2030. The Acute Ischemic Stroke Therapeutics Market is dominated by key players such as, Amgen Inc., AbbVie Inc., Boehringer Ingelheim GmbH, Novo Nordisk A/S, and Eli Lilly and Company.
According to Intent Market Research, the Antiseptic Bathing Products Market is expected to grow from USD 19.5 billion in 2023 at a CAGR of 4.9% to touch USD 27.1 billion by 2030. The Antiseptic Bathing Products Market is dominated by key players such as, BD (Becton, Dickinson and Company), Ecolab, Medline Industries, LP, and Perrigo Company plc.
According to Intent Market Research, the AI in Cardiology Market is expected to grow from USD 1.7 billion in 2023 at a CAGR of 15.6% to touch USD 4.6 billion by 2030. The AI in Cardiology Market is dominated by key players such as, Google Health (Alphabet Inc.), IBM Corporation, Philips Healthcare, Cardiogram, and Medtronic plc.
According to Intent Market Research, the Antimicrobial Resistance Diagnostics Market is expected to grow from USD 3.2 billion in 2023 at a CAGR of 10.3% to touch USD 6.3 billion by 2030. The Antimicrobial Resistance Diagnostics Market is dominated by key players such as, F. Hoffmann-La Roche Ltd., bioMerieux, BD, Molsid, and Accelerate Diagnostics, Inc..
According to Intent Market Research, the Biological Sample Collection Kits Market is expected to grow from USD 7.9 billion in 2023 at a CAGR of 7.6% to touch USD 13.1 billion by 2030. The Biological Sample Collection Kits Market is dominated by key players such as Becton, Dickinson and Company (BD), Merck KGaA, Qiagen N.V., Roche Diagnostics, Hologic, Inc., Cardinal Health, Inc., Medtronic plc, and Bio-Rad Laboratories, Inc.
As per Intent Market Research, the Artificial Tendons and Ligaments Market was valued at USD 158.7 million in 2023 and will surpass USD 591.5 million by 2030; growing at a CAGR of 20.7% during 2024 - 2030.
According to Intent Market Research, the Robotic Prosthetics Market is expected to grow from USD 2.1 billion in 2023 at a CAGR of 8.8% to touch USD 3.8 billion by 2030. The Robotic Prosthetics Market is dominated by key players such as, Bionik Laboratories Corp., Amedica Corporation, EKSO Bionics Holdings, Inc., Rex Bionics, and InnoMotion GmbH.
According to Intent Market Research, the Adeno Associated Virus Vector Manufacturing Market is expected to grow from USD 1.1 billion in 2023 at a CAGR of 18.3% to touch USD 3.6 billion by 2030. The Adeno Associated Virus Vector Manufacturing Market is dominated by key players such as, Wuxi AppTec, Lonza Group, Pharmaron, Regenxbio, and Oxford Biomedica.
According to Intent Market Research, the Vital Signs Monitoring Market is expected to grow from USD 9.5 billion in 2023 at a CAGR of 5.5% to touch USD 13.8 billion by 2030. The Vital Signs Monitoring Market is dominated by key players such as, Cura Medical, Cardinal Health, Honeywell, Siemens Healthineers, and Medtronic.
According to Intent Market Research, the ADME Toxicology Testing Market is expected to grow from USD 5.5 billion in 2023 at a CAGR of 8.7% to touch USD 9.8 billion by 2030. The ADME Toxicology Testing Market is dominated by key players such as, Charles River Laboratories, F. Hoffmann-La Roche Ltd, Yposkesi, Inc., Creative Biogene, and Pfizer Inc.
According to Intent Market Research, the Osteoarthritis Therapeutics Market is expected to grow from USD 7.9 billion in 2023 at a CAGR of 6.9% to touch USD 12.6 billion by 2030. The Osteoarthritis Therapeutics Market is dominated by key players such as, Amgen Inc., AbbVie Inc., Eli Lilly and Company, Regeneron Pharmaceuticals, Inc., and Horizon Therapeutics plc
According to Intent Market Research, the Sterility Indicators Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 11.2% to touch USD 2.0 billion by 2030. The Sterility Indicators Market is dominated by key players such as 3M Company, Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Merck KGaA, Cantel Medical Corp., Ecolab Inc., SteriPack, Biomérieux SA, and Halyard Health, Inc.
According to Intent Market Research, the Continuous Bioprocessing Market is expected to grow from USD 201.7 million in 2023 at a CAGR of 16.9% to touch USD 602.9 million by 2030. The Continuous Bioprocessing Market is dominated by key players such as 3M, Bionet, Corning Incorporated, Danaher, Fujifilm, Meissner, Merck and Repligen.
According to Intent Market Research, the Biologics CDMO Market is expected to grow from USD 19.4 billion in 2023 at a CAGR of 18.9% to touch USD 65.2 billion by 2030. The Biologics CDMO Market is dominated by key players such as Lonza Group, Samsung Biologics, WuXi Biologics, Catalent, Inc., Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific (Patheon), AbbVie Contract Manufacturing, AGC Biologics, Rentschler Biopharma SE
According to Intent Market Research, the AI in Life Science Analytics Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 12.3% to touch USD 6.3 billion by 2030. The AI in Life Science Analytics Market is dominated by key players such as, BioSymetrics, Alphabet Inc., Deep Genomics, Roche, and IBM.
According to Intent Market Research, the Acinetobacter Pneumonia Therapeutics Market is expected to grow from USD 421.6 million in 2023 at a CAGR of 7.8% to touch USD 715.3 million by 2030. The Acinetobacter Pneumonia Therapeutics Market is dominated by key players such as, AstraZeneca, AbbVie Inc., GlaxoSmithKline plc, Eli Lilly and Company, and Novartis International AG.
According to Intent Market Research, the Absorbable Nasal Implant Devices Market is expected to grow from USD 417.4 million in 2023 at a CAGR of 11.8% to touch USD 912.4 million by 2030. The Absorbable Nasal Implant Devices Market is dominated by key players such as, Acelity L.P. Inc., Acclarent, Inc., EpiBone, Entellus Medical, Inc. (part of Stryker), and Genzyme Corporation (part of Sanofi).
According to Intent Market Research, the Ablation Technology Market is expected to grow from USD 7.3 billion in 2023 at a CAGR of 8.8% to touch USD 13.2 billion by 2030. The Ablation Technology Market is dominated by key players such as, AngioDynamics, Abbott Laboratories, Boston Scientific, Olympus Corporation, and Halyard Health.
According to Intent Market Research, the 3D Ultrasound Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 7.9% to touch USD 4.7 billion by 2030. The 3D Ultrasound Market is dominated by key players such as, Bracco Imaging S.p.A., Alpinion Medical Systems Co., Ltd., EchoNous, Inc., Philips Healthcare, and Fujifilm Holdings Corporation.
According to Intent Market Research, the Spinal Implants and Devices Market is expected to grow from USD 12.2 billion in 2023 at a CAGR of 6.3% to touch USD 18.6 billion by 2030. The Spinal Implants and Devices Market is dominated by key players such as, Alphatec Holdings, Inc., Aesculap Implant Systems, LLC, Globus Medical, Inc., SeaSpine Holdings Corporation, and K2M Group Holdings, Inc.
According to Intent Market Research, the Acute Invasive Aspergillosis Treatment Market is expected to grow from USD 2.1 billion in 2023 at a CAGR of 5.7% to touch USD 3.1 billion by 2030. The Acute Invasive Aspergillosis Treatment Market is dominated by key players such as, Astellas Pharma Inc., Amphastar Pharmaceuticals, Inc., Cipla Inc., Novartis AG, and F. Hoffmann-La Roche Ltd.
According to Intent Market Research, the Acetazolamide Market is expected to grow from USD 346.2 million in 2023 at a CAGR of 6.5% to touch USD 539.3 million by 2030. The Acetazolamide Market is dominated by key players such as, Alvogen, Inc., Alembic Pharmaceuticals Ltd., Cipla Ltd., Sun Pharmaceutical Industries Ltd., and Hikma Pharmaceuticals PLC.
According to Intent Market Research, the Radiofrequency Ablation Device Market is expected to grow from USD 4.3 billion in 2023 at a CAGR of 9.0% to touch USD 7.9 billion by 2030. The Radiofrequency Ablation Device Market is dominated by key players such as, Boston Scientific Corporation, Medtronic PLC, AngioDynamics, Inc., Smith & Nephew PLC, and Merit Medical Systems, Inc.
According to Intent Market Research, the Active Implantable Medical Devices Market is expected to grow from USD 21.6 billion in 2023 at a CAGR of 6.8% to touch USD 34.3 billion by 2030. The Active Implantable Medical Devices Market is dominated by key players such as, Biotronik SE & Co. KG, Abbott Laboratories, LivaNova PLC, William Demant Holding A/S, and Medtronic plc.
According to Intent Market Research, the Abdominal Pads Market is expected to grow from USD 674.2 million in 2023 at a CAGR of 8.9% to touch USD 1,227.4 million by 2030. The Abdominal Pads Market is dominated by key players such as, B. Braun Melsungen AG, 3M Company, Derma Sciences, Inc., Coloplast Corporation, and Johnson & Johnson.
According to Intent Market Research, the 3D Printed Wearable Market is expected to grow from USD 3.4 billion in 2023 at a CAGR of 9.6% to touch USD 6.4 billion by 2030. The 3D Printed Wearable Market is dominated by key players such as, Adidas AG, 3D Systems Corporation, EOS GmbH, Shapeways, Inc., and Hewlett-Packard (HP) Inc..
According to Intent Market Research, the 3D Printed Prosthetics Market is expected to grow from USD 1.3 billion in 2023 at a CAGR of 15.1% to touch USD 3.5 billion by 2030. The 3D Printed Prosthetics Market is dominated by key players such as, BioDigital Prosthetics, 3D Systems Corporation, Enabling the Future, ProsFit Technologies, and Limbitless Solutions, Inc.
According to Intent Market Research, the Outsourced Semiconductor Assembly and Test Services Market is expected to grow from USD 35.7 billion in 2023 at a CAGR of 6.5% to touch USD 55.6 billion by 2030. The Outsourced Semiconductor Assembly and Test Services (OSAT) Market is dominated by key players such as Amkor Technology, ASE Technology Holding, ChipMOS Technologies Inc., HANA Mircon Corporation Business, Shenzhen CPET Electronics Co., Ltd., and UTAC Holdings Ltd.
According to Intent Market Research, the Healthcare Workforce Management System Market is expected to grow from USD 1.5 billion in 2023 at a CAGR of 9.0% to touch USD 2.8 billion by 2030. The Healthcare Workforce Management System Market is dominated by key players such as Kronos Incorporated, Infor, Inc., Oracle Corporation, ADP, LLC, SAP SE, IBM Corporation, McKesson Corporation, Cerner Corporation, and GE Healthcare.
According to Intent Market Research, the Brucellosis Vaccines Market is expected to grow from USD 226.6 million in 2023 at a CAGR of 4.2% to touch USD 303.1 million by 2030. The Brucellosis Vaccines Market is dominated by key players such as Merck Animal Health, Zoetis Inc., Elanco Animal Health, Bayer AG, Vetoquinol S.A., Ceva Santé Animale, HIPRA, S.A., Biogenesis Bago S.A, Novartis Animal Health and Indian Immunologicals Ltd.
According to Intent Market Research, the Electron Microscopy Market is expected to grow from USD 3.4 billion in 2023 at a CAGR of 8.1% to touch USD 5.9 billion by 2030. The Electron Microscopy Market is dominated by key players such as, Bruker Corporation, Advantest Corporation, Hitachi High-Tech Corporation, Olympus Corporation, and JEOL Ltd.
According to Intent Market Research, the Direct-To-Consumer Laboratory Testing Market is expected to grow from USD 3.8 billion in 2023 at a CAGR of 17.3% to touch USD 11.6 billion by 2030. The Direct-To-Consumer Laboratory Testing Market is dominated by key players such as, CircleDNA, 23andMe, Everlywell, Orig3n, and Home Access Health Corporation.
According to Intent Market Research, the Intrauterine Devices Market is expected to grow from USD 3.9 billion in 2023 at a CAGR of 9.0% to touch USD 7.1 billion by 2030. The Intrauterine Devices Market is dominated by key players such as Bayer, CooperSurgical, AbbVie Inc. (Allergan Plc), Pregna International Limited, DKT International, Medisafe Distribution, HLL Lifecare Limited, and Eurosurgical Ltd.
This report on the global ambulance stretchers market provides a comprehensive analysis of the market's dynamics, including product types, technologies, equipment applications, and regional market assessments.
According to Intent Market Research, the Accountable Care Solutions Market is expected to grow from USD 21.3 billion in 2023 at a CAGR of 8.2% to touch USD 37.1 billion by 2030. The Accountable Care Solutions Market is dominated by key players such as, Athenahealth, Allscripts, Cerner Corporation, McKesson, and Epic Systems.
According to Intent Market Research, the Medical Health Screening Market is expected to grow from USD 12.0 billion in 2023 at a CAGR of 7.2% to touch USD 19.6 billion by 2030. The Medical Health Screening Market is dominated by key players such as Abbott, Eurofins Scientific, F. Hoffmann-La Roche Ltd, GE Healthcare, Laboratory Corporation of America Holdings and Lifelabs.
According to Intent Market Research, the Biometrics as a Service in Healthcare Market is expected to grow from USD 0.6 billion in 2023 at a CAGR of 17.9% to touch USD 1.9 billion by 2030. The Biometrics as a Service in Healthcare Market is dominated by key players such as Bio-Key International, Crossmatch Technologies (HID Global), Fingerprint Cards AB, Gemalto (Thales Group), IBM, IDEMIA and M2SYS Technology.
According to Intent Market Research, the Achondroplasia Treatment Market is expected to grow from USD 0.03 million in 2023 at a CAGR of 59.8% to touch USD 0.8 million by 2030. The Achondroplasia Treatment Market is dominated by key players such as BioMarin Pharmaceutical, Eli Lilly and Company, Genetics Pharmaceuticals, Pfizer Inc., Novartis AG and Swedish Orphan Biovitrum.
According to Intent Market Research, the 3D Bioprinting Market is expected to grow from USD 1.4 billion in 2023 at a CAGR of 12.0% to touch USD 3.1 billion by 2030. The 3D Bioprinting Market is dominated by key players such as Organovo Holdings, Inc., 3D Systems Corporation, Aspect Biosystems Ltd., Allevi, Inc., EnvisionTEC (Now part of Desktop Metal), Allevi, Inc. and Cellink AB.
According to Intent Market Research, the Radiopharmaceuticals Market is expected to grow from USD 6.1 billion in 2023 at a CAGR of 7.6% to touch USD 10.2 billion by 2030. The Radiopharmaceuticals Market is dominated by key players such as, Eckert & Ziegler, Bayer, GE Healthcare, Siemens, and Lantheus.
According to Intent Market Research, the Radiology Services Market is expected to grow from USD 18.4 billion in 2023 at a CAGR of 6.6% to touch USD 28.7 billion by 2030. The Radiology Services Market is dominated by key players such as, Alliance HealthCare, Agfa HealthCare, Healthscope, Teleradiology Solutions, and Nuffield Health.
According to Intent Market Research, the DNA Repair Drugs Market is expected to grow from USD 7.9 billion in 2023 at a CAGR of 14.4% to touch USD 20.2 billion by 2030. The DNA Repair Drugs Market is dominated by key players such as Amgen Inc., AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Inc. and Merck KGaA.
According to Intent Market Research, the DNA Diagnostics Market is expected to grow from USD 15.2 billion in 2023 at a CAGR of 8.4% to touch USD 26.7 billion by 2030. The DNA Diagnostics Market is dominated by key players such as, Agilent Technologies, Abbott, Illumina, Roche, and Thermo Fisher Scientific.
According to Intent Market Research, the Critical Limb Ischemia Treatment Market is expected to grow from USD 3.1 billion in 2023 at a CAGR of 9.9% to touch USD 6.0 billion by 2030. The Critical Limb Ischemia Treatment Market is dominated by key players such as Abbott, AngioDynamics, B. Braun Medical Ltd, Boston Scientific Corporation and Cook Medical
According to Intent Market Research, the Coronary Artery Bypass Graft Market is expected to grow from USD 14.5 billion in 2023 at a CAGR of 8.2% to touch USD 25.3 billion by 2030. The Coronary Artery Bypass Graft Market is dominated by key players such as, Artivion, Abbott, Edwards Lifesciences, Teleflex, and Johnson & Johnson.
According to Intent Market Research, the Bispecific Antibodies Market is expected to grow from USD 3.3 billion in 2023 at a CAGR of 15.6% to touch USD 9.0 billion by 2030. The Bispecific Antibodies Market is dominated by key players such as, AstraZeneca, Amgen, Chugai Pharmaceutical, Novartis, and Genentech
According to Intent Market Research, the AI in Clinical Trials Market is expected to grow from USD 1.8 billion in 2023 at a CAGR of 23.0% to touch USD 7.6 billion by 2030. The AI in Clinical Trials Market is dominated by key players such as Ardigen, BioSymetrics, Euretos, Exscientia, IBM Corporation and Insilico Medicine.
According to Intent Market Research, the CAR T-Cell Therapy Market is expected to grow from USD 4.4 billion in 2023 at a CAGR of 32.5% to touch USD 31.2 billion by 2030. The CAR T-Cell Therapy Market is dominated by key players such as Autolus Therapeutics, Bristol-Myers Squibb Company, CARsgen Therapeutics Holdings Limited, CRISPR Therapeutics, Gilead Sciences and IASO Biotherapeutics.
According to Intent Market Research, the Mice Model Market is expected to grow from USD 1.4 billion in 2023 at a CAGR of 8.8% to touch USD 2.6 billion by 2030. The Mice Model Market is dominated by key players such as Biocytogen, Charles River Laboratories, Cyagen, GemPharmatech, Harbour BioMed, Inotiv and Ozgene Pty Ltd.
According to Intent Market Research, the Pressure Monitoring Market is expected to grow from USD 13.4 billion in 2023 at a CAGR of 6.3% to touch USD 20.6 billion by 2030. The Pressure Monitoring Market is dominated by key players such as, GE Healthcare, A&D Company, Medtronic, Siemens, and Omron.
According to Intent Market Research, the Rabies Vaccine Market is expected to grow from USD 1.6 billion in 2023 at a CAGR of 5.7% to touch USD 2.3 billion by 2030. The Rabies Vaccine Market is dominated by key players such as, Boehringer Ingelheim, Merck Animal Health, Elanco, Zoetis, and Serum Institute of India.
According to Intent Market Research, the Remote Health Monitoring Market is expected to grow from USD 83.8 billion in 2023 at a CAGR of 10.6% to touch USD 169.3 billion by 2030. The Remote Health Monitoring Market is dominated by key players such as, Medtronic, Abbott, GE Healthcare, ResMed, and iHealth Labs.
According to Intent Market Research, the Patient Engagement Solutions Market is expected to grow from USD 25.8 billion in 2023 at a CAGR of 11.8% to touch USD 56.4 billion by 2030. The Patient Engagement Solutions Market is dominated by key players such as, McKesson, Allscripts, eClinicalWorks, Oracle, and IBM.
According to Intent Market Research, the Clinical Communication and Collaboration Market is expected to grow from USD 2.5 billion in 2023 at a CAGR of 11.1% to touch USD 5.1 billion by 2030. The Clinical Communication and Collaboration Market is dominated by key players such as Ascom, Avaya LLC, Baxter International, Cisco Systems, Everbridge and Hidden Brains InfoTech.
According to Intent Market Research, the Medical Gas Equipment Market is expected to grow from USD 19.0 billion in 2023 at a CAGR of 5.7% to touch USD 28.0 billion by 2030. The Medical Gas Equipment Market is dominated by key players such as GCE Group, Genstar Technologies, Linde Plc, Messer SE & Co. KGaA, Norco, Rotarex and SOL Spa.
According to Intent Market Research, the eClinical Solutions Market is expected to grow from USD 11.4 billion in 2023 at a CAGR of 10.8% to touch USD 23.3 billion by 2030. The eClinical Solutions Market is dominated by key players such as Clario, Clinion, ICON, IQVIA, and Medidata.
According to Intent Market Research, the Dermocosmetics Market is expected to grow from USD 41.3 billion in 2023 at a CAGR of 10.7% to touch USD 84.4 billion by 2030. The Dermocosmetics Market is dominated by key players such as, Bioderma Laboratories, Beiersdorf, Johnson & Johnson, Procter & Gamble, and L'Oréal.
According to Intent Market Research, the Atrial Fibrillation Drugs Market is expected to grow from USD 16.0 billion in 2023 at a CAGR of 4.6% to touch USD 21.9 billion by 2030.
According to Intent Market Research, the Anesthesia Information Management Systems Market is expected to grow from USD 850.2 million in 2023 at a CAGR of 7.6% to touch USD 1,421.2 million by 2030. The Anesthesia Information Management Systems Market is dominated by key players such as Cerner Corporation, DOCUSYS AE, Drägerwerk AG & Co. KGaA, Fukuda Denshi Co., Ltd., GE Healthcare and iMDsoft.
According to Intent Market Research, the Anesthesia Devices Market is expected to grow from USD 9.4 billion in 2023 at a CAGR of 7.6% to touch USD 15.7 billion by 2030. The Anesthesia Devices Market is dominated by key players such as, Drägerwerk, Medtronic, Fisher & Paykel, Stryker, and Hill-Rom.
According to Intent Market Research, the Aesthetic Lasers Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 9.9% to touch USD 2.3 billion by 2030. The Aesthetic Lasers Market is dominated by key players such as Alma Lasers, Candela Corporation, Cutera, Inc., Cynosure and El.En. SpA.
According to Intent Market Research, the 3D Printed Surgical Models Market is expected to grow from USD 335.1 million in 2023 at a CAGR of 16.2% to touch USD 956.3 million by 2030. The 3D Printed Surgical Models Market is dominated by key players such as 3D Printlife, 3D Systems, Inc., Axial3D, Desktop Metal, Inc., Formlabs and Materialize.
According to Intent Market Research, the Cannabis Testing Market is expected to grow from USD 2.0 billion in 2023 at a CAGR of 12.1% to touch USD 4.4 billion by 2030. The Cannabis Testing Market is dominated by key players such as Agilent Technologies, Danaher Corporation, Merck, PerkinElmer, Restek Corporation and SC Labs.
According to Intent Market Research, the Antihypertensive Drugs Market is expected to grow from USD 25.1 billion in 2023 at a CAGR of 3.6% to touch USD 32.2 billion by 2030. The Antihypertensive Drugs Market is dominated by key players such as, Bayer, AstraZeneca, Boehringer Ingelheim, Pfizer, and Merck & Co.
According to Intent Market Research, the Pharmaceutical Analytical Testing Market is expected to grow from USD 8.1 billion in 2023 at a CAGR of 7.2% to touch USD 13.2 billion by 2030. The Pharmaceutical Analytical Testing Market is dominated by key players such as, Charles River Laboratories, Thermo Fisher Scientific, Eurofins Scientific, WuXi AppTec, and Labcorp.
According to Intent Market Research, the Acne Medication Market is expected to grow from USD 12.5 billion in 2023 at a CAGR of 5.5% to touch USD 18.2 billion by 2030. The Acne Medication Market is dominated by key players such as AbbVie Inc., Bausch Health Companies, Bayer, Botanix, GALDERMA and GSK.
According to Intent Market Research, the Lyophilization Equipment Market is expected to grow from USD 7.2 billion in 2023 at a CAGR of 7.7% to touch USD 12.2 billion by 2030. The Lyophilization Equipment Market is dominated by key players such as, BUCHI, HOF Sonderanlagenbau, IMA S.p.A, Labconco, and Millrock Technology.
According to Intent Market Research, the 3D Printed Medical Implants Market is expected to grow from USD 3.5 billion in 2023 at a CAGR of 11.7% to touch USD 7.6 billion by 2030. The 3D Printed Medical Implants Market is dominated by key players such as, Allevi, Inc., 3D Systems, Formlabs, Stratasys, and HP Inc.
According to Intent Market Research, the 3D Bioengineered Skin Grafts Market is expected to grow from USD 156.3 million in 2023 at a CAGR of 24.3% to touch USD 718.2 million by 2030. The 3D Bioengineered Skin Grafts Market is dominated by key players such as, Tissue Regenix, AbbVie, MediWound, Organogenesis, and Tides Medical.
According to Intent Market Research, the Sepsis Therapeutics Market is expected to grow from USD 2.7 billion in 2023 at a CAGR of 6.3% to touch USD 4.2 billion by 2030. The Sepsis Therapeutics Market is dominated by key players such as, AstraZeneca, Abbott, Eli Lilly and Company, Pfizer, and Merck & Co.
According to Intent Market Research, the Immunotherapy Drugs Market is expected to grow from USD 247.2 billion in 2023 at a CAGR of 14.6% to touch USD 641.8 billion by 2030. The Immunotherapy Drugs Market is dominated by key players such as, Amgen, AbbVie, Bristol Myers Squibb, Regeneron Pharmaceuticals, Merck, Sanofi, Pfizer, Roche, Novartis, and Eli Lilly.
According to Intent Market Research, the Epigenetics Diagnostics Market is expected to grow from USD 2.3 billion in 2023 at a CAGR of 13.9% to touch USD 5.8 billion by 2030. The Epigenetics Diagnostics Market is dominated by key players such as, Bio-Rad Laboratories, Agilent, Merck KGaA, Thermo Fisher Scientific, and Qiagen.
According to Intent Market Research, the Digital PCR (dPCR) and Real-time PCR (qPCR) Market is expected to grow from USD 8.9 billion in 2023 at a CAGR of 7.9% to touch USD 15.2 billion by 2030. The Digital PCR (dPCR) and Real-time PCR (qPCR) Market is dominated by key players such as Danaher, Roche, Thermo Fisher Scientific, Merck, QIAGEN, Bio-Rad Laboratories, Becton, Dickinson and Company, and Abbott.
According to Intent Market Research, the Acute Lymphocytic Leukemia Therapeutics Market is expected to grow from USD 3.1 billion in 2023 at a CAGR of 7.4% to touch USD 5.1 billion by 2030. The Acute Lymphocytic Leukemia Therapeutics Market is dominated by key players such as Bristol-Myers Squibb Company, Novartis, Roche, Celgene Corporation, Amgen, Gilead Sciences, AstraZeneca, Janssen Pharmaceuticals, Sanofi, and Incyte Corporation.
According to Intent Market Research, the Acute Care Telemedicine Market is expected to grow from USD 21.6 billion in 2023 at a CAGR of 15.3% to touch USD 58.2 billion by 2030. The Acute Care Telemedicine Market is dominated by key players such as Eagle Telemedicine, Enghouse Video, Orbit Health, Relymd, Sciencesoft USA Corporation, SynergenX, and Teladoc Health.
According to Intent Market Research, the Telehealth & Telemedicine Market is expected to grow from USD 115.2 billion in 2023 at a CAGR of 16.3% to touch USD 331.4 billion by 2030. The Telehealth & Telemedicine Market is dominated by key players such as Amwell, Cisco Systems, Encounter Telehealth, GE Healthcare, Global Med, MDLIVE Inc., MeMD Inc., Oracle, Siemens Healthcare, and Teladoc Health.
According to Intent Market Research, the Biologics Market is expected to grow from USD 374.6 billion in 2023 at a CAGR of 9.1% to touch USD 689.6 billion by 2030. The Biologics Market is dominated by key players such as Roche Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Eli Lilly, AstraZeneca, and Sanofi.
According to Intent Market Research, the Computer Vision in Healthcare Market is expected to grow from USD 4.2 billion in 2023 at a CAGR of 21.8% to touch USD 16.8 billion by 2030. The Computer Vision in Healthcare Market is dominated by key players such as, Canon, GE Healthcare, IBM, NVIDIA, Philips Healthcare, AMD, Siemens, and Microsoft.
According to Intent Market Research, the Biosimilar Monoclonal Antibody Market is expected to grow from USD 374.6 billion in 2023 at a CAGR of 9.1% to touch USD 689.6 billion by 2030. The Biosimilar Monoclonal Antibody Market is dominated by key players such as Amgen, BIOCAD, Biocon, Biogen, Novartis, Pfizer, Shanghai Henlius Biotech, and Teva Pharmaceutical.
According to Intent Market Research, the Neonatal Ventilators Market is expected to grow from USD 358.5 million in 2023 at a CAGR of 5.2% to touch USD 512.5 million by 2030. The Neonatal Ventilators Market is dominated by key players such as Air Liquide Medical Systems, Becton, Dickinson and Company, Drägerwerk AG & Co., GE Healthcare, Getinge, HAMILTON MEDICAL, ICU Medical, Philips Healthcare, and Medtronic.
According to Intent Market Research, the Biologics Contract Development Market is expected to grow from USD 14.7 billion in 2023 at a CAGR of 7.3% to touch USD 24.1 billion by 2030. The Biologics Contract Development Market is dominated by key players such as, Charles River Laboratories, Boehringer Ingelheim, Lonza, Samsung Biologics, Rentschler Biopharma, and Parexel.
According to Intent Market Research, the Monoclonal Antibody (mAB) Therapeutics Market is expected to grow from USD 225.3 billion in 2023 at a CAGR of 13.5% to touch USD 547.3 billion by 2030. The Monoclonal Antibody (mAB) Therapeutics Market is dominated by key players such as, Biogen, Boehringer Ingelheim, Bristol Myers Squibb Company, Abbvie, Eli Lilly, Takeda, Roche, Sanofi, and Merck.
According to Intent Market Research, the Rehabilitation Equipment Market is expected to grow from USD 12.3 billion in 2023 at a CAGR of 4.0% to touch USD 16.2 billion by 2030. The Rehabilitation Equipment Market is dominated by key players such as Arjo, Bioness, BioXtreme, Dynatronics, Halma, Honeywell, Invacare Corporation, Philips Healthcare, Medline Industries, and Medtronic.
According to Intent Market Research, the Lacrimal Devices Market is expected to grow from USD 27.5 million in 2023 at a CAGR of 5.5% to touch USD 39.9 billion by 2030. The Lacrimal Devices Market is dominated by key players such as Alcon, Bausch and Lomb, Bess Medical Technology, BVI Medical, Cook Group, FCI Ophthalmics, Gunther Weiss Scientific, Kaneka Pharma America, and OASIS Medical.
According to Intent Market Research, the ePrescribing Market is expected to grow from USD 1.4 billion in 2023 at a CAGR of 25.4% to touch USD 6.6 billion by 2030. The ePrescribing Market is competitive; where the prominent players include Allscripts Healthcare Solutions, athenahealth, Cerner Corporation, DrFirst, Epic Systems Corporation, GE Healthcare, Henry Schein, NextGen Healthcare, RelayHealth, and Surescripts.
According to Intent Market Research, the Contrast Enhanced Ultrasound Market is expected to grow from USD 1.4 billion in 2023 at a CAGR of 6.0% to touch USD 2.1 billion by 2030. The Contrast Enhanced Ultrasound Market is dominated by key players such as Acusphere, Inc., Bracco, Canon Medical Systems, GE Healthcare, Philips Healthcare, and Siemens Healthineers.
According to Intent Market Research, the Chromatography Reagents Market is expected to grow from USD 6.1 billion in 2023 at a CAGR of 8.6% to touch USD 10.9 billion by 2030. The Chromatography Reagents Market is dominated by key players such as, Agilent Technologies, Bio-Rad, Cytiva, Danaher, Roche Diagnostics, Thermo Fisher Scientific, and Merck.
According to Intent Market Research, the Cell Isolation Market is expected to grow from USD 4.1 billion in 2023 at a CAGR of 12.1% to touch USD 9.1 billion by 2030. The Cell Isolation Market is dominated by key players such as, Bio-Rad Laboratories, Becton, Dickinson and Company, QIAGEN, Agilent Technologies, Lonza, Sartorius AG, and Roche.
According to Intent Market Research, the Brain Computer Interface Market is expected to grow from USD 2.7 billion in 2023 at a CAGR of 15.6% to touch USD 7.4 billion by 2030. The Brain Computer Interface Market is dominated by key players such as, EMOTIV, Advanced Brain Monitoring, Medtronic, Integra LifeSciences, Natus Medical, and Neuralink.
According to Intent Market Research, the Ambulatory Cardiac Monitoring Devices Market is expected to grow from USD 6.4 billion in 2023 at a CAGR of 11.2% to touch USD 13.4 billion by 2030. The Ambulatory Cardiac Monitoring Devices Market is dominated by key players such as, GE Healthcare, Abbott, Medtronic, Hill-Rom, Biotronik, Boston Scientific, and Nihon Kohden.
According to Intent Market Research, the Antibody Therapeutics Market is expected to grow from USD 293.3 billion in 2023 at a CAGR of 13.9% to touch USD 728.8 billion by 2030. The Antibody Therapeutics Market is dominated by key players such as, Biogen, Abbvie, Eli Lilly, Novartis, Sanofi, Takeda, and Merck.
According to Intent Market Research, the Real World Evidence Solutions Market is expected to grow from USD 2.5 billion in 2023 at a CAGR of 8.4% to touch USD 4.4 billion by 2030. The Real World Evidence Solutions market is competitive; where the prominent players include Cegedim Health Data, IBM, IQVIA, Labcorp, Oracle, SAS Institute, Thermo Fisher Scientific, and Trinity.
According to Intent Market Research, the Clinical Trial Imaging Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 7.6% to touch USD 2.0 billion by 2030. The clinical trial imaging market is dominated by key players such as BioTelemetry, ICON plc, IXICO, Calyx Group, Biomedical Systems Corporation, and Medpace.
According to Intent Market Research, the 3D Cell Culture Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 14.1% to touch USD 3.0 billion by 2030. The 3D Cell Culture Market is dominated by key players such as Avantor, Corning, Emulate, Kirkstall, Lonza, Merck, and Thermo Fisher Scientific.
According to Intent Market Research, the Virtual Care Market is expected to grow from USD 8.5 billion in 2023 at a CAGR of 30.8% to touch USD 55.5 billion by 2030. The Virtual Care Market is competitive; where the prominent players include AMD Global Telemedicine, American Well Corporation, CHI Health, Aetna CVS Health, GE Healthcare, MDLIVE, Medocity, Oracle, Teladoc Health, and United HealthCare Services.
According to Intent Market Research, the Radiation Shielding Material Market is expected to grow from USD 688 million in 2023 at a CAGR of 5.8% to touch USD 1,022 million by 2030. The radiation shielding material market is dominated by key players such as ETS-LINDGREN, Infab Corporation, Gravita India, Mayco Industries, A&L Shielding, and Radiation Protection Products.
According to Intent Market Research, the Remote Patient Monitoring Market is expected to grow from USD 15.9 billion in 2023 at a CAGR of 19.5% to touch USD 55.3 billion by 2030. The remote patient monitoring market is dominated by key players such as Biotronik SE, AliveCor, TytoCare, Brook, iRhythm Technologies, Bardy Diagnostics, and Aktiia.
According to Intent Market Research, the Clinical Chemistry Analyzers Market is expected to grow from USD 12.3 billion in 2023 at a CAGR of 4.4% to touch USD 16.7 billion by 2030. The clinical chemistry analyzers market is dominated by key players such as Roche Diagnostics, Danaher, Abbott, Thermo Fisher Scientific, Siemens Healthineers, and Sysmex Corporation.
According to Intent Market Research, the Contract Development & Manufacturing Market is expected to grow from USD 179.4 billion in 2023 at a CAGR of 10.4% to touch USD 359.3 billion by 2030. The Contract Development & Manufacturing Market is competitive; where the prominent players include Aenova Group, Baxter Biopharma Solutions, Boehringer Ingelheim, Catalent, Jubilant Biosys, Lonza Group, Patheon, PCI Services, Pfizer, and Recipharm
According to Intent Market Research, the Research Antibodies & Reagents Market is expected to grow from USD 11.2 billion in 2023 at a CAGR of 6.0% to touch USD 16.9 billion by 2030. The research antibodies & reagents market is dominated by key players such as Abcam, Merck, Cell Signaling Technology, Roche, Danaher, Lonza, Agilent, and Illumnia.
According to Intent Market Research, the Preimplantation Genetic Testing Market is expected to grow from USD 667 million in 2023 at a CAGR of 10.9% to touch USD 1,374 million by 2030. The preimplantation genetic testing market is dominated by key players such as Agilent, Thermo Fisher Scientific, Illumina, Revvity, Abbott, Takara Bio, Qiagen, MedGenome, and Berry Genomics.
According to Intent Market Research, the Respiratory Care Devices Market is expected to grow from USD 20.7 billion in 2023 at a CAGR of 7.3% to touch USD 34.0 billion by 2030. The respiratory care devices market is dominated by key players such as Philips Healthcare, GE Healthcare, ResMed, Air Liquide Medical Systems, Medtronic, Baxter, and OMRON Healthcare.
According to Intent Market Research, the Cystatin C Assay Market is expected to grow from USD 357 million in 2023 at a CAGR of 6.9% to touch USD 571 million by 2030. The cystatin C assay market is dominated by key players such as Abbott, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Randox Laboratories, Diasys Diagnostic Systems, and Sino Biological.
According to Intent Market Research, the Active Pharmaceutical Ingredients Market is expected to grow from USD 160.4 billion in 2023 at a CAGR of 5.4% to touch USD 231.1 billion by 2030. The Active Pharmaceutical Ingredients Market is competitive; where the prominent players include AstraZeneca, BASF, Boehringer Ingelheim, Dow Chemical, DuPont, Evonik, Roche, GSK, and Pfizer.
According to Intent Market Research, the Radiotherapy Market is expected to grow from USD 6.3 billion in 2023 at a CAGR of 4.6% to touch USD 8.7 billion by 2030. The radiotherapy market is dominated by key players such as Siemens Healthineers, IBA Dosimetry, Accuray Incorporated, Hitachi High-Tech Corporation, Philips Healthcare, Provision Healthcare, and Carl Zeiss Meditec.
According to Intent Market Research, the RNA therapeutics market is expected to grow from USD 13.0 billion in 2023 at a CAGR of 5.1% to touch USD 18.5 billion by 2030. The RNA therapeutics market is dominated by key players such as Moderna, Novartis, Silence Therapeutics, CRISPR Therapeutics, Sirnaomics, Sanofi, and Ionis Pharmaceuticals.
According to Intent Market Research, the Topical Drug Delivery Market is expected to grow from USD 90.3 billion in 2023 at a CAGR of 11.2% to touch USD 190.4 billion by 2030. The Topical Drug Delivery market is competitive; where the prominent players include 3M, Bayer, Cipla, Galderma, GlaxoSmithKline, Abbvie, Novartis, and Pfizer.
According to Intent Market Research, the Single Use Assemblies Market is expected to grow from USD 2.4 billion in 2023 at a CAGR of 15.1% to touch USD 6.4 billion by 2030. The Single Use Assemblies Market is dominated by key players such as, Thermo Fisher Scientific, Merck, Sartorius, Merck, Danaher, Parker Hannifin, and Newage Industries.
According to Intent Market Research, the Mass Spectrometry Market is expected to grow from USD 5.2 billion in 2023 at a CAGR of 7.0% to touch USD 8.3 billion by 2030. The Mass Spectrometry Market is competitive; where the prominent players include SCIEX, Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, PerkinElmer, Analytik Jena Gmbh, JASCO, Bruker, and Shimadzu Corporation.
According to Intent Market Research, the Single-Cell Analysis Market is expected to grow from USD 3.3 billion in 2023 at a CAGR of 14.8% to touch USD 8.7 billion by 2030. The single cell analysis market is competitive; where the prominent players include Becton, Dickinson and Company, Danaher Corporation, Merck, QIAGEN, Thermo Fisher Scientific, Illumina, Agilent, and 10x Genomics.
According to Intent Market Research, the Dental 3D Printing Market is expected to grow from USD 2.8 billion in 2023 at a CAGR of 17.2% to touch USD 8.5 billion by 2030. The Dental 3D Printing Market is competitive; where the prominent players include SLM Solutions, 3D Systems, Formlabs, Desktop Metal, Dentsply Sirona, GE Additive, Align Technology, and Stratasys.
According to Intent Market Research, the Laboratory Information Management System (LIMS) Market is expected to grow from USD 1.6 billion in 2023 at a CAGR of 14.0% to touch USD 4.0 billion by 2030. The Laboratory Information Management System (LIMS) market is competitive; where the prominent players include LabWare, LabVantage Solutions, Thermo Fisher Scientific, Agilent Technologies, LabLynx, Labtrack, Illumina, Clinisys, and Blaze Systems.
According to Intent Market Research, the Laboratory Information System (LIS) Market is expected to grow from USD 2.3 billion in 2023 at a CAGR of 10.2% to touch USD 4.5 billion by 2030. The laboratory information system market is dominated by key players such as Orchard Software Corporation, Clinisys, Oracle, Veradigm, Aspyra, Labware, CompuGroup Medical, and Ligolab Information System.
According to Intent Market Research, the Primary Cells Market is expected to grow from USD 1.6 billion in 2023 at a CAGR of 10.0% to touch USD 3.1 billion by 2030. The primary cells market is competitive; where the prominent players include Thermo Fisher Scientific, Merck, Lonza, Corning, Allcells, Promocell, Charles River, and Creative Bioarray.
According to Intent Market Research, the veterinary surgical instruments market is expected to grow from USD 1.3 billion in 2023 at a CAGR of 7.1% to touch USD 2.1 billion by 2030. The beneficial insects market is competitive; where the prominent players include B. Braun Vet Care, Ethicon, Integra Lifesciences, Jorgen KRUUSE A/S (Henry Schein), Jorgensen Labs, Medtronic, and Neogen Corporation.
According to Intent Market Research, the Chemiluminescence Immunoassay Market is expected to grow from USD 12.6 billion in 2023 at a CAGR of 7.0% to touch USD 20.2 billion by 2030. The chemiluminescence immunoassay market is competitive; where the prominent players include Roche, Danaher, Siemens Healthineers, Abbott Laboratories, DiaSorin, Shenzhen Mindray, Wiener, and Sysmex Corporation.
According to Intent Market Research, the Revenue Cycle Management Market is expected to grow from USD 47.2 billion in 2023 at a CAGR of 10.6% to touch USD 95.5 billion by 2030. The revenue cycle management market is competitive; where the prominent players include R1 RCM, Oracle, Optum, GE Healthcare, McKesson Corporation, 3M, Athena Health, and Plutus Health.
According to Intent Market Research, the IVD Contract Manufacturing Market is expected to grow from USD 14.7 billion in 2023 at a CAGR of 11.0% to touch USD 30.5 billion by 2030. The IVD contract manufacturing market is competitive; where the prominent players include Sanmina Corporation, Jabil, TE Connectivity, Celestica, West Pharmaceutical Services, Avioq, Namera, and Fujirebio.
According to Intent Market Research, the CT/NG Testing Market is expected to grow from USD 1.7 billion in 2023 at a CAGR of 8.1% to touch USD 2.9 billion by 2030. The CT/NG testing market is competitive; where the prominent players include Roche Diagnostics, Hologic, Thermo Fisher Scientific, Abbott, Bio-Rad Laboratories, Siemens Healthineers, and Danaher.
According to Intent Market Research, the CRISPR Market is expected to grow from USD 3.3 billion in 2023 at a CAGR of 15.0% to touch USD 8.7 billion by 2030. The CRISPR market is competitive; where the prominent players include Thermo Fisher Scientific, Merck, Agilent Technologies, Lonza, PerkinElmer, CRISPR Therapeutics, Intellia Therapeutics, Beam Therapeutics, and Danaher.
According to Intent Market Research, the Near Infrared Imaging Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 9.7% to touch USD 1.8 billion by 2030. The Near Infrared Imaging Market is competitive; where the prominent players include Stryker, KARL STORZ, Carl Zeiss Meditec, Thermo Fisher Scientific, Medtronic, Leica Microsystems, Olympus Corporation and PerkinElmer.
According to Intent Market Research, the Preparative and Process Chromatography Market is expected to grow from USD 10.7 billion in 2023 at a CAGR of 6.3% to touch USD 16.4 billion by 2030. The preparative and process chromatography market is dominated by key players such as Merck, Agilent, Danaher, Sartorius, Bio-Rad Laboratories, Thermo Fisher Scientific, PerkinElmer, Bruker, Shimadzu, and Waters Corporation.
According to Intent Market Research, the Breast Imaging Market is expected to grow from USD 4.2 billion in 2023 at a CAGR of 8.0% to touch USD 7.1 billion by 2030. The Breast Imaging Market is competitive; where the prominent players include GE Healthcare, Hologic, Canon, Siemens Healthineers, Philips Healthcare, FUJIFILM Holdings Corporation, among others.
According to Intent Market Research, the Cell Based Assays Market is expected to grow from USD 17.9 billion in 2023-e at a CAGR of 7.9% to touch USD 30.5 billion by 2030. The Cell Based Assays Market is competitive; where the prominent players include Merck, Becton, Dickinson and Company, Lonza, Thermo Fisher Scientific, PerkinElmer, Abbott, Roche, and Danaher.
According to Intent Market Research, the Temperature Management Systems Market is expected to grow from USD 2.9 billion in 2023-e at a CAGR of 4.4% to touch USD 4.0 billion by 2030. The Temperature Management Systems Market is dominated by key players such as 3M, Asahi-Kasei Corporation, Becton, Dickinson and Company, ICU Medical, Gentherm Incorporated, GE Healthcare, Medtronic, Stryker, and Dragerwerk.
According to Intent Market Research, the Particle Size Analysis Market is expected to grow from USD 400 million in 2023-e at a CAGR of 5.4% to touch USD 600 million by 2030. The particle size analysis market is dominated by key players such as Danaher, HORIBA, Bettersize Instruments, Spectris, Verder Scientific, METTLER TOLEDO, Sympatec, and Shimadzu Corporation.
According to Intent Market Research, the Particle Therapy Market is expected to grow from USD 0.7 billion in 2023-e at a CAGR of 7.6% to touch USD 1.2 billion by 2030. The particle therapy market is dominated by key players such as IBA Worldwide, ProTom International, Hitachi, Varian Medical Systems, Toshiba Medical Systems, Advanced Oncotherapy, Optivus Proton Therapy, and Danfysik.
According to Intent Market Research, the Diagnostic Imaging Market is expected to grow from USD 25.1 billion in 2023-e at a CAGR of 5.0% to touch USD 35.4 billion by 2030. The diagnostic imaging market is dominated by key players such as GE Healthcare, Siemens Healthineers, Canon, Philips Healthcare, Hologic, Agfa-Gevaert Group, Planmed, and Fujifilm.
According to Intent Market Research, the Nucleic Acid Isolation and Purification Market is expected to grow from USD 6.0 billion in 2023-e at a CAGR of 7.6% to touch USD 10.1 billion by 2030. The nucleic acid isolation and purification market is dominated by key players such as Agilent Technologies, Danaher, Bio-Rad Laboratories, Thermo Fisher Scientific, Roche, Merck, Illumina, and Takara Bio.
According to Intent Market Research, the Patient-Derived Xenograft / PDX Model Market is expected to grow from USD 356 million in 2023-e at a CAGR of 13.7% to touch USD 818 million by 2030. The patient-derived xenograft model market is dominated by key players such as Wuxi Apptec, Charles River Laboratories, The Jackson Laboratory, Taconic Biosciences, Urosphere, Xentech, Inotiv, and Oncodesign Precision Medicine.
According to Intent Market Research, the Peptide Synthesis Market is expected to grow from USD 0.6 billion in 2023-e at a CAGR of 6.9% to touch USD 0.9 billion by 2030. The peptide synthesis market is competitive; where the prominent players include Thermo Fisher Scientific, Merck, Kaneka Corporation, GenScript Biotech Corporation, Bachem Holding, Biotage, Syngene, Mesa Labs, ProteoGenix, and Bio-Synthesis Inc.
According to Intent Market Research, the Medical Aesthetics Market is expected to grow from USD 14.6 billion in 2023-e at a CAGR of 10.5% to touch USD 29.4 billion by 2030. The medical aesthetics market is dominated by key players such as AbbVie, Ipsen, Alma Lasers, Cynosure, Galderma, Medytox, Merz, Cutera Inc., Fotona, amongst others.
According to Intent Market Research, the Biomedical Textiles Market is expected to grow from USD 18.8 billion in 2023-e at a CAGR of 15.9% to touch USD 52.7 billion by 2030. The Biomedical Textiles Market is dominated by key players such as Cardinal Health, Smith & Nephew, Integra LifeSciences, Johnson & Johnson, Medline, DSM, Becton, Dickinson & Company, and Medtronic.
According to Intent Market Research, the Healthcare Cloud Computing Market is expected to grow from USD 43.9 billion in 2023-e at a CAGR of 17.1% to touch USD 133.1 billion by 2030. The healthcare cloud computing market is dominated by key players such as Microsoft, AWS, IBM, Carecloud, Siemens Healthineers, GE Healthcare, Allscripts, Fujifilm, and Dell.
According to Intent Market Research, the Digital Pathology Market is expected to grow from USD 1.2 billion in 2023-e at a CAGR of 11.1% to touch USD 2.5 billion by 2030. The digital pathology market is dominated by key players such as Philips, Hamamatsu Photonics, Indica Labs, Roche, Hologic, Fujifilm, Paige AI, and Danaher.
According to Intent Market Research, the Vascular Access Device Market is expected to grow from USD 5.2 billion in 2023-e at a CAGR of 7.1% to touch USD 8.9 billion by 2030. The vascular access device market is dominated by key players such as 3M, ICU Medical, Teleflex, AngioDynamics, Medtronic, Argon Medical Devices, and B. Braun.
According to Intent Market Research, the Ultrasound Market is expected to grow from USD 8.1 billion in 2023-e at a CAGR of 5.8% to touch USD 12.1 billion by 2030. The ultrasound market is dominated by key players such as GE Healthcare, Philips, Samsung, Neusoft, Canon Medical Systems, Siemens, and Fujifilm.
According to Intent Market Research, the Digital Dentistry Market is expected to grow from USD 6.9 billion in 2023-e at a CAGR of 10.4% to touch USD 13.8 billion by 2030. The Digital Dentistry Market is dominated by key players such as Dentsply Sirona, Envista Holdings Corporation, 3M, Planmeca, Vatech, Roland DG Corporation, 3D Systems, and Ivoclar Vivadent.
According to Intent Market Research, the Diagnostic Electrocardiograph Market is expected to grow from USD 7.7 billion in 2023-e at a CAGR of 6.4% to touch USD 11.9 billion by 2030. The diagnostic electrocardiograph market is dominated by key players such as GE HealthCare, Philips Healthcare, Nihon Kohden, OSI Systems, Medtronic, Mindray, Schiller AG, and Hill-Rom Holdings.
According to Intent Market Research, the Digital Pharmacy Market is expected to grow from USD 19.4 billion in 2023-e at a CAGR of 9.5% to touch USD 35.9 billion by 2030. The digital pharmacy market is dominated by key players such as Cigna, CVS Health, Walmart, Walgreen, Pharmeasy, Apollo Pharmacy, Amazon, Apex Pharmacy, and Optum, Inc.
According to Intent Market Research, the Optometry Equipment Market is expected to grow from USD 4.3 billion in 2023-e at a CAGR of 6.5% to touch USD 6.7 billion by 2030. The optometry equipment industry market is dominated by key players such as Carl Zeiss Meditec, Alcon, Canon, Bausch Health, Johnson & Johnson, Revenio Group, and NIDEK CO.
According to Intent Market Research, the Spatial Genomics & Transcriptomics Market is expected to grow from USD 4.5 billion in 2023-e at a CAGR of 11.9% to touch USD 9.9 billion by 2030. The spatial genomics & transcriptomics market is competitive; where the prominent players include Illumina, 10X Genomics, Bruker, Bio-Rad Laboratories, Seven Bridges Genomics, Danaher, and PerkinElmer.
According to Intent Market Research, the ERCP market is expected to grow from USD 1.9 billion in 2023-e at a CAGR of 4.0% to touch USD 2.5 billion by 2030. The ERCP market is dominated by key players such as CONMED Corporation, Boston Scientific, B. Braun, Medtronic, Telemed Systems, Steris, Medi-Globe, Olympus, and Fujifilm.
According to Intent Market Research, the veterinary infectious disease diagnostics market is expected to grow from USD 2.3 billion in 2023-e at a CAGR of 9.5% to touch USD 4.3 billion by 2030. The veterinary infectious disease diagnostics market is dominated by key players such as Zeotis, bioMérieux, Qiagen, Heska Corporation, Idexx Laboratories, INDICAL Bioscience, Thermo Fisher Scientific, and MEGACOR.
According to Intent Market Research, the Positron Emission Tomography Market is expected to grow from USD 2.7 billion in 2023-e at a CAGR of 5.0% to touch USD 3.8 billion by 2030. The positron emission tomography market is dominated by key players such as Siemens Healthineers, GE Healthcare, Canon, Philips, Mediso, Oncovision, Kindsway Biotech, and Prescient Medical Imaging.
According to Intent Market Research, the Oncology Information System Market is expected to grow from USD 7.8 billion in 2023 at a CAGR of 7.9% to touch USD 13.3 billion by 2030. The oncology information system market is dominated by key players such as Siemens Healthineers, Philips Healthcare, GE Healthcare, Allscripts Healthcare, IBM, Accuray Incorporated, Epic systems, and Roche.
According to Intent Market Research, the Medical Supplies Market is expected to grow from USD 141.1 billion in 2023-e at a CAGR of 4.1% to touch USD 186.4 billion by 2030. The medical supplies market is dominated by key players such as Cardinal Health, Medtronic, Becton, Dickinson and Company, B. Braun, Abbott, Stryker, 3M, Smith & Nephew, and Thermo Fisher Scientific.
According to Intent Market Research, the Microcatheters Market is expected to grow from USD 0.8 billion in 2023 at a CAGR of 9.2% to touch USD 1.3 billion by 2030. The microcatheters market is competitive; where the prominent players include Boston Scientific, Stryker Corporation, Teleflex Incorporated, Kaneka Corporation, Becton Dickinson and Company, Asahi Intecc, Johnson & Johnson, and Medtronic.
According to Intent Market Research, the Molecular Diagnostics Market is expected to grow from USD 15.8 billion in 2023 at a CAGR of 10.9% to touch USD 32.6 billion by 2030. The molecular diagnostics market is competitive; where the prominent players include Abbott, Illumina, Danaher, Roche Diagnostics, Hologic, Thermo Fisher Scientific, Siemens Healthineers, Becton, Dickinson and Company, and Qiagen.
According to Intent Market Research, the Smart Pills Market is expected to grow from USD 0.6 billion in 2023 at a CAGR of 11.7% to touch USD 1.3 billion by 2030. The Smart Pills Market is competitive; where the prominent players include Medtronic, ElectRx, BodyCap, CapsoVision, IntroMedic, Check-Cap, IntroMedic, AnX Robotica, Olympus, and Otsuka America Pharmaceutical.
According to Intent Market Research, the Stem Cell Therapy Market is expected to grow from USD 5.1 billion in 2023 at a CAGR of 19.3% to touch USD 17.7 billion by 2030. The stem cell therapy market is dominated by key players such as AllCells, ANTEROGEN, Becton, Dickinson, & Company, Takeda Pharmaceutical, RTI Surgical, Merck, Pharmicell, and Thermo Fisher Scientific.
According to Intent Market Research, the Amniotic Products Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 6.9% to touch USD 1.4 billion by 2030. The amniotic products market is competitive; where the prominent players include Organogenesis, Smith+Nephew, Integra LifeSciences, MIMEDX, Stryker, Tides Medical, and MTF Biologics.
According to Intent Market Research, the High Throughput Screening Market is expected to grow from USD 24.4 billion in 2023 at a CAGR of 11.1% to touch USD 51.0 billion by 2030. The High Throughput Screening Market is competitive; where the prominent players include Thermo Fisher Scientific, Lonza, Agilent Technologies, Eurofins Scientific, Merck, Danaher Corporation, and PerkinElmer.
According to Intent Market Research, the ATP Assays Market is expected to grow from USD 0.3 billion in 2023 at a CAGR of 7.1% to touch USD 0.5 billion by 2030. The ATP Assays Market is competitive; where the prominent players include Thermo Fisher Scientific, Promega Corporation, Merck, PerkinElmer, Agilent Technologies, 3M, and Agilent.
According to Intent Market Research, the Digital Health Market is expected to grow from USD 181.0 billion in 2023-e at a CAGR of 6.4% to touch USD 279.4 billion by 2030. The digital health market is dominated by key players such as Abbott, Beckman Coulter, Boston Scientific, Medtronic, J&J MedTech, Philips Healthcare, GE Healthcare, Siemens Healthineers, Teladoc, Samsung Healthcare, and McKesson.
According to Intent Market Research, the Pen Needles Market is expected to grow from USD 1.5 billion in 2023-e at a CAGR of 8.6% to touch USD 2.7 billion by 2030.The Pen Needles market is dominated by key players such as Novo Nordisk, B.Braun, Nipro, Owen Mumford, Arkray and Ultimed.
According to Intent Market Research, the Softgel Capsules Market is expected to grow from USD 1.1 billion in 2023-e at a CAGR of 5.8% to touch USD 1.6 billion by 2030. The Softgel Capsules Market is dominated by key players such as United Laboratories, CAPTEK, Fuji Capsule, Softgel Technologies, Sirio Pharma, and Gelita.
According to Intent Market Research, the Feminine Hygiene Products Market is expected to grow from USD 23.4 billion in 2023-e at a CAGR of 5.0% to touch USD 33.0 billion by 2030. The Feminine Hygiene Products market is dominated by key players such as Kimberly-Clark Corporation, Procter & Gamble, Kao Corporation, Johnson & Johnson, Essity Aktiebolag, and Daio Paper Corporation.
According to Intent Market Research, the Vaccine Adjuvants Market is expected to grow from USD 0.8 billion in 2023-e at a CAGR of 6.5% to touch USD 1.3 billion by 2030. The vaccine adjuvants market is dominated by key players such as Agenus, Dynavax Technologies, Merck, Eubiologics, Hawaii, Aurorium, and Seppic.
According to Intent Market Research, the Vaccines Market is expected to grow from USD 47.7 billion in 2023-e at a CAGR of 9.7% to touch USD 91.2 billion by 2030. The vaccines market is dominated by key players such as Pfizer, Panacea Biotec, Novovax, Daiichi Sankyo, Emergent, CSL, Sanofi, and Bharat Biotec.
According to Intent Market Research, the Analytical Standards Market is expected to grow from USD 1.4 billion in 2023-e at a CAGR of 6.5% to touch USD 2.2 billion by 2030. The Analytical Standards market is dominated by key players such as Merck, Agilent Technologies, Waters Corporation, LGC Standards, Restek Corporation, and PerkinElmer.
According to Intent Market Research, the Clinical Trials Market is expected to grow from USD 45.8 billion in 2023-e at a CAGR of 8.2% to touch USD 79.6 billion by 2030. The clinical trials market is dominated by key players such as Laboratory Corporation of America Holdings, Parexel International Corporation, Icon PLC, IQVIA, Charles River Laboratories, Advanced Clinical, ACM Global Laboratories, and WuXi AppTec.
According to Intent Market Research, the Pharmaceutical Packaging Equipment Market is expected to grow from USD 8.4 billion in 2023-e at a CAGR of 6.5% to touch USD 13.1 billion by 2030. The pharmaceutical packaging equipment market is dominated by key players such as Vanguard Pharmaceutical Machinery, Syntegon Technology, ACG Worldwide, Optima Packaging Group, Trustar Pharma Pack Equipment, MG2 s.r.l., Marchesini Group, Romaco, and Multivac.
According to Intent Market Research, the Cardiac Safety Services Market is expected to grow from USD 700 million in 2023-e at a CAGR of 11.2% to touch USD 1,471 million by 2030. The cardiac safety services market is dominated by key players such as Laboratory Corporation of America Holdings, Medpace, Certara, Ncardia, SGS, Icon, Charles River Laboratories and Philips.
According to Intent Market Research, the Antimicrobial Resistance Surveillance Market is expected to grow from USD 5.6 billion in 2023-e at a CAGR of 5.1% to touch USD 7.9 billion by 2030. The antimicrobial resistance surveillance market is dominated by key players such as Luminex Corporation, Thermo Fisher, Danaher, Becton, Dickinson and Company, Accelerate Diagnostics, BioSpace, Bio-Rad, Roche, Merck, and Bruker
According to Intent Market Research, the Blood Screening Market is expected to grow from USD 2.3 billion in 2023-e at a CAGR of 6.7% to touch USD 3.6 billion by 2030. The blood screening market is dominated by key players such as Roche, Abbott, bioMérieux, Bio-Rad Laboratories, Siemens Healthineers, Danaher, and Thermo Fisher Scientific.
The Gene Therapy market is projected to grow from USD 8.6 billion in 2023-e to USD 32.4 billion by 2030, registering a CAGR of 20.9% during the forecast period. The Gene Therapy market is dominated by key players such as Novartis, Uniqure, Johnson & Johnson, Orchard Therapeutics, Biogen, Gilead Sciences, Bristol-Myers Squibb, and Sarepta Therapeutics.
According to Intent Market Research, the Antibody Drug Conjugates Market is expected to grow from USD 9.3 billion in 2023-e at a CAGR of 14.7% to touch USD 24.2 billion by 2030. The antibody drug conjugates market is dominated by key players such as Pfizer, Daiichi Sankyo, Seagen, Takeda, Gilead Sciences, Roche, Astellas, ADC Therapeutics, ImmunoGen, AbbVie.
According to Intent Market Research, the Wound Care Market is expected to grow from USD 20.4 billion in 2023-e at a CAGR of 5.4%to touch USD 29.5 billion by 2030. The Wound Care Market is dominated by key players such as Medtronic, 3M, Cardinal Health, Convatec, B. Braun, Paul Hartmann, and Organogenesis.
According to Intent Market Research, the Stem Cell Manufacturing Market is expected to grow from USD 12.1 billion in 2023-e at a CAGR of 10.8% to touch USD 24.8 billion by 2030. The stem cell manufacturing market is competitive; where the prominent players include Thermo Fisher Scientific, Merck, Lonza, Danaher, Sartorius, Becton, Dickinson, and Company, Takara Bio, Getinge, and Eppendorf.
According to Intent Market Research, the Advance Directives Market is expected to grow from USD 116.9 billion in 2023-e at a CAGR of 18.3% to touch USD 378.0 billion by 2030. The advance directives market is dominated by key players such as Iris Healthcare, Bronson Healthcare, Thoroughcare, New Century Health, ADvault, Vynca, WiserCare, and Sharp HealthCare.
According to Intent Market Research, the Molecular Quality Controls Market is expected to grow from USD 0.2 billion in 2023-e at a CAGR of 5.6% to touch USD 0.3 billion by 2030. The Molecular Quality Controls Market is competitive; where the prominent players include Abbott, Danaher, Bio-Rad, Roche, Thermo Fisher Scientific, Grifols, QuidelOrtho, and Randox Laboratories.
According to Intent Market Research, the Multimodal Imaging Market is expected to grow from USD 4.0 billion in 2023-e at a CAGR of 5.2% to touch USD 5.6 billion by 2030. The Multimodal Imaging Market is dominated by key players such as Philips, GE Healthcare, Canon, Siemens Healthineers, Neusoft Corporation, Fujifilm, Bruker, and Topcon Corporation.
According to Intent Market Research, the MRI Systems market is expected to grow from USD 4.9 billion in 2023-e at a CAGR of 4.5% to touch USD 6.7 billion by 2030. The MRI Systems market is dominated by key players such as Philips, Siemens Healthineers, GE Healthcare, Fonar Corporation, Fujifilm, Canon, and Neusoft Medical Systems.
According to Intent Market Research, the Metagenomic Sequencing Market is expected to grow from USD 1.9 billion in 2023-e at a CAGR of 17.0% to touch USD 5.7 billion by 2030. The Metagenomic Sequencing Market is competitive; where the prominent players include Thermo Fisher Scientific, QIAGEN, PerkinElmer, Illumina, Pacific Biosciences, and Eurofins Scientific.
According to Intent Market Research, the Metabolism Assays Market is expected to grow from USD 1.4 billion in 2023-e at a CAGR of 7.3% to touch USD 2.2 billion by 2030. The Metabolism Assays Market is dominated by key players such as, Abcam, Thermo Fisher, Merck, Agilent Technologies, Sartorius, and Mitsubishi Corporation.
According to Intent Market Research, the Medical Equipment Maintenance Market is expected to grow from USD 46.3 billion in 2023-e at a CAGR of 10.1% to touch USD 90.8 billion by 2030. The Medical Equipment Maintenance Market is dominated by key players such as GE Healthcare, Siemens Healthineers, Philips, Medtronic, Hitachi, and B. Braun.
According to Intent Market Research, the Leukapheresis Market is expected to grow from USD 62 million in 2023-e at a CAGR of 7.9% to touch USD 105 million by 2030. The leukapheresis market is dominated by key players such as Asahi Kasei, Fresenius, Terumo BCT, Haemonetics Corporation, Lonza, ZenBio, Macopharma, and Miltenyi Biotec.
Medical Radiation Shielding Market By Product (Lead Sheet, Doors, Windows, Shields, Booths, Curtain, X-Ray), By Solution (Cyclotron, PET, Radiation Therapy, CT, MRI), By End-use (Hospitals, Diagnostic Centers, Clinics & ASCs), and by Region; Global Insights & Forecast (2024 – 2030)
According to Intent Market Research, the Medical Device Testing Market is expected to grow from USD 10.1 billion in 2023-e at a CAGR of 4.4% to touch USD 13.7 billion by 2030. The Medical Device Testing Market is dominated by key players such as Intertek Group, Eurofins Scientific, SGS, Bureau Veritas, Charles River Laboratories, and TÜV SÜD.
According to Intent Market Research, the Label Free Detection Market is expected to grow from USD 0.5 billion in 2023-e at a CAGR of 8.2% to touch USD 0.9 billion by 2030. The label free detection market is competitive; where the prominent players include Danaher, Sartorius, Waters Corporation, PerkinElmer, Attana, Spectris, and Shimadzu Corporation.
According to Intent Market Research, the Insulin Delivery Devices Market is expected to grow from USD 29.2 billion in 2023-e at a CAGR of 8.0% to touch USD 50.0 billion by 2030. The insulin delivery devices market is dominated by key players such as Becton & Dickinson, Eli Lilly, Cerur Corporation, Biocon, Wockhardt, Medtronic, Roche, and Owen Mumford.
According to Intent Market Research, the Intensity Modulated Radiotherapy Market is expected to grow from USD 2.1 billion in 2023-e at a CAGR of 4.8% to touch USD 2.8 billion by 2030. The intensity modulated radiotherapy market is dominated by key players such as Elekta, Siemens Healthineers, Accuray Incorporated, Varian Medical Systems, Brainlab, Philips, and Hitachi.
According to Intent Market Research, the Breast Lesion Localization Market is expected to grow from USD 0.3 billion in 2023-e at a CAGR of 6.1% to touch USD 0.4 billion by 2030. The Breast Lesion Localization Market is dominated by key players such as Intramedical Imaging, GE Healthcare, Becton & Dickinson, Argon Medical, Medline Industries, Hologic, and Dragerwerk.
According to Intent Market Research, the Bone Cement & Glue Market is expected to grow from USD 1.6 billion in 2023-e at a CAGR of 6.0% to touch USD 2.3 billion by 2030. The Bone Cement & Glue Market is dominated by key players such as Stryker, Zimmer Biomet, Smith+Nephew, Medtronic, Cardinal Health, DePuy Synthes, and Enovis.
According to Intent Market Research, the Intraoral/ IOL Scanners Market is expected to grow from USD 0.6 billion in 2023-e at a CAGR of 10.6% to touch USD 1.1 billion by 2030. The Intraoral/ IOL scanners market is competitive; where the prominent players include DENTSPLY SIRONA, Align Technology, Envista, 3shape, Fussen, Launca, 3DISC, and Medit Corp.
According to Intent Market Research, the Blood Culture Tests Market is expected to grow from USD 4.9 billion in 2023-e at a CAGR of 7.5% to touch USD 8.2 billion by 2030. The Blood Culture Tests Market is dominated by key players such as Roche Diagnostics, Becton, Dickinson and Company, Biomérieux, Himedia Laboratories, Scenker Biological Technology, Thermo Fisher Scientific, and Danaher.
According to Intent Market Research, the Incontinence Care Products Market is expected to grow from USD 11.9 billion in 2023-e at a CAGR of 5.1% to touch USD 16.9 billion by 2030. The Incontinence Care Products Market is dominated by key players such as Essity Aktiebolag, Procter & Gamble, Kimberly-Clark, Hartmann, Unicharm, Ontex BV, amongst others
According to Intent Market Research, the Bioimpedance Analyzers Market is expected to grow from USD 0.5 billion in 2023-e at a CAGR of 9.7% to touch USD 1.0 billion by 2030. The Bioimpedance Analyzers Market is dominated by key players such as Tanita Corporation, InBody, EVOLT, OMRON Corporation, RJL Systems, and Seca GmbH.
According to Intent Market Research, the In Vitro Toxicology Testing Market is expected to grow from USD 10.3 billion in 2023-e at a CAGR of 9.0% to touch USD 18.9 billion by 2030. The In Vitro Toxicology Testing Market is dominated by key players such as Thermo Fisher Scientific, SGS, Merck, Eurofins Scientific, Intertek, Laboratory Corporation of America Holdings, Agilent, amongst others.
According to Intent Market Research, the Immunoassay Market is expected to grow from USD 33.3 billion in 2023-e at a CAGR of 5.4% to touch USD 48.2 billion by 2030. The Immunoassay Market is dominated by key players such as Abbott, Roche, Qiagen, Agilent, Thermo Fisher Scientific, Merck, Danaher, Siemens Healthineers, amongst others.
According to Intent Market Research, the Humanized Mouse and Rat Model Market is expected to grow from USD 0.2 billion in 2023-e at a CAGR of 6.0% to touch USD 0.4 billion by 2030. The Humanized Mouse and Rat Model Market is competitive; where the prominent players include Charles River Laboratories, Taconic Biosciences, Crown Bioscience, Amgen, Champions Oncology, Hera BioLabs, among others.
According to Intent Market Research, the Cleanroom Technologies Market is expected to grow from USD 7.8 billion in 2023-e at a CAGR of 6.3% to touch USD 12.0 billion by 2030. The cleanroom technologies market is dominated by key players such as Dynarex, Colandis, ABN Cleanroom Technology, Clean Rooms International, Kimberly-Clark, DuPont, and Illinois Tool Works.
According to Intent Market Research, the Cellulose Ether & Derivatives Market is expected to grow from USD 7.7 billion in 2023-e at a CAGR of 8.6% to touch USD 13.7 billion by 2030. The cellulose ether & derivatives market is dominated by key players such as Dow, Ashland, Fenchem, Shandong Head, Rayonier Advanced Materials, Shin-Etsu Chemical, LOTTE Fine Chemicals, and DKS Co. Ltd.
According to Intent Market Research, the Cell Culture Media Market is expected to grow from USD 5.9 billion in 2023-e at a CAGR of 15.5% to touch USD 16.1 billion by 2030. The cell culture media market is dominated by key players such as Thermo Fisher Scientific, Merck KGaA, Corning Incorporated, Becton & Dickinson, FUJIFILM Irvine Scientific, and Danaher Corporation.
According to Intent Market Research, the HLA Typing for Transplant Market is expected to grow from USD 767 million in 2023-e at a CAGR of 5.8% to touch USD 1,138 million by 2030. The HLA Typing for Transplant Market is dominated by key players such as Thermo Fisher Scientific, Illumina, Roche, Immucor, QIAGEN, CareDX, Bio-Rad Laboratories, among others.
According to Intent Market Research, the Cell Analysis Market is expected to grow from USD 19.2 billion in 2023-e at a CAGR of 10.4% to touch USD 38.4 billion by 2030. The cell analysis market is dominated by key players such Agilent Technologies, Bio-Rad, Illumina, Thermo Fisher Scientific, PerkinElmer, Becton & Dickinson, Standard Biotools, amongst others.
According to Intent Market Research, the Hemostats Market is expected to grow from USD 2.5 billion in 2023-e at a CAGR of 6.2%to touch USD 3.9 billion by 2030. The Hemostats Market is dominated by key players such as Johnson & Johnson, Baxter, Becton & Dickinson, Pfizer, B. Braun, Medtronic, Stryker, among others.
According to Intent Market Research, the Cell Therapy Technologies Market is expected to grow from USD 4.0 billion in 2023-e at a CAGR of 12.8% to touch USD 9.2 billion by 2030. The cell therapy technologies market is dominated by key players such as Thermo Fisher Scientific, Merck, Danaher, Terumo, Becton & Dickinson, Lonza, amongst others.
According to Intent Market Research, the Glycated Albumin Assay Market is expected to grow from USD 0.2 billion in 2023-e at a CAGR of 8.6% to touch USD 0.3 billion by 2030. The Glycated Albumin Assay Market is competitive; where the prominent players include Asahi Kasei, PerkinElmer, Tecan Lifesciences, Agilent, Beijing Strong Biotechnologies, Diazyme Laboratories, DxGen Corp., Weldon Biotech, among others.
According to Intent Market Research, the Animal Genetics Market is expected to grow from USD 6.3 billion in 2023-e at a CAGR of 6.9% to touch USD 10.1 billion by 2030. The animal genetics market is dominated by key players such as Neogen Corporation, Genus, Urus, EW Group, Groupe Grimaud, Topigs Norsvin, CRV Holding, amongst others.
According to Intent Market Research, the AI in Pathology Market is expected to grow from USD 0.01 billion in 2023-e at a CAGR of 14.6% to touch USD 0.1 billion by 2030. The AI in pathology market is dominated by key players such as Koninklijke Philips, Tribun Health, Lumea, Hoffmann-La Roche Ltd, and Hologic.
According to Intent Market Research, the Blood Group Typing Market is expected to grow from USD 1.9 billion in 2023-e at a CAGR of 8.2% to touch USD 3.3 billion by 2030. The blood group typing market is dominated by key players such as Bio-Rad Laboratories, Grifols, QuidelOrtho Corporation, Merck, Quotient, Danaher, Thermo Fisher Scientific, and Immucor.
According to Intent Market Research, the Flow Cytometry Market is expected to grow from USD 4.5 billion in 2023-e at a CAGR of 7.8% to touch USD 7.5 billion by 2030. The Flow Cytometry Market is dominated by key players such as Danaher, Thermo Fisher Scientific, Agilent, bioMérieux, Bio-Rad Laboratories, Becton & Dickinson, among others.
According to Intent Market Research, the Gene Editing Market is expected to grow from USD 5.0 billion in 2023-e at a CAGR of 14.5% to touch USD 12.9 billion by 2030. The Gene Editing Market is competitive; where the prominent players include Merck, Thermo Fisher Scientific, GenScript, Tecan Life Sciences, Agilent, Lonza, PerkinElmer, among others.
According to Intent Market Research, the Adhesion Barrier Market is expected to grow from USD 0.6 billion in 2023-e at a CAGR of 6.9% to touch USD 1.0 billion by 2030. The adhesion barrier market is dominated by key players such as Johnson & Johnson, Becton & Dickinson, Integra LifeSciences, Baxter, Bioscompass, Atrium Medical, Anika Therapeutics, MAST Biosurgery, amongst others.
According to Intent Market Research, the Biotechnology Contract Manufacturing Market is expected to grow from USD 15.8 billion in 2023-e at a CAGR of 7.8% to touch USD 26.8 billion by 2030. The biotechnology contract manufacturing market is dominated by key players such as Catalent, Samsung Biologics, Fujifilm Holdings, Eurofins Scientific, Thermo Fisher Scientific, Lonza, Merck and WuXi Biologics.
According to Intent Market Research, the Biopsy Devices Market is expected to grow from USD 6.2 billion in 2023-e at a CAGR of 13.5% to touch USD 15.1 billion by 2030. The biopsy devices market is dominated by key players such as Becton & Dickinson, Cook Group Incorporated, Hologic, B. Braun, Stryker, Devicor Medical Products, and Olympus Corporation.
According to Intent Market Research, the AI in Medical Diagnostics Market is expected to grow from USD 1.2 billion in 2023-e at a CAGR of 22.6% to touch USD 5.2 billion by 2030. The AI in Medical Diagnostics market is dominated by key players such as Microsoft, Alphabet, NVIDIA Corporation, Merative, GE Healthcare, Digital Diagnostics, Siemens Healthineers, Philips, amongst others.
According to Intent Market Research, the Precision Medicine Market is expected to grow from USD 30.7 billion in 2023-e at a CAGR of 11.4% to touch USD 59.3 billion by 2030. The precision medicine market is competitive, the prominent players in the global market include AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Catalent, Eli Lilly, Gilead Sciences, Johnson & Johnson, Lonza, Merck, Novartis, Parexel, Pfizer, Roche, Sanofi, Takeda Pharmaceutical, amongst others.
Plasma Fractionation Market was valued at USD 31.7 billion in 2023-e and will surpass USD 50.1 billion by 2030; growing at a CAGR of 7.8% during 2024 - 2030
According to Intent Market Research, the AI in Drug Discovery Market is expected to grow from USD 850 million in 2023-e at a CAGR of 40.5% to touch USD 4,500 million by 2030. The AI in drug discovery market is a competitive market, the prominent players in the global market include BenevolentAI, BioXcel Therapeutics, Deep Genomics, Exscientia, Google, Insilico Medicine, IQVIA, Labcorp, Microsoft, NVIDIA, and Recursion.
The Breast Biopsy Devices Market is expected to grow from USD 1.8 billion in 2023-e to USD 3.4 billion by 2030, at a CAGR of 9.7% during the forecast period.
The Biomarkers Market is expected to grow from USD 79.3 billion in 2023-e to USD 187.4 billion by 2030, at a CAGR of 14.7% during the forecast period
AI in Cell and Gene Therapy Market; By Technology (Machine Learning (ML) {Deep Learning, Supervised Learning, Unsupervised Learning}, Generative AI, Natural Language Processing), By Indication (Oncology, Immunology, Cardiology & Neurology, Infectious Disease), By Application (Clinical Trials, Drug Discovery, Precision Medicine), By End-User (Biopharmaceutical Companies, Research Institutes, Healthcare Providers) and By Region; Global Insights & Forecast (2024 - 2030)
AI-Based Predictive Maintenance Market Size Analysis, By Components (Software {Integrate, Standalone}, Service {Cloud}
Published Date: 30 May , 2024
AI-Based Predictive Maintenance Market Size Analysis, By Components (Software {Integrate, Standalone}, Service {Cloud}
Published Date: 02 June , 2024